Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Outcome Assessment (Health Care): Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure).Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Pregnancy Outcome: Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Antitubercular Agents: Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Directly Observed Therapy: A treatment method in which patients are under direct observation when they take their medication or receive their treatment. This method is designed to reduce the risk of treatment interruption and to ensure patient compliance.Cognitive Therapy: A direct form of psychotherapy based on the interpretation of situations (cognitive structure of experiences) that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior.Outcome and Process Assessment (Health Care): Evaluation procedures that focus on both the outcome or status (OUTCOMES ASSESSMENT) of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process (ASSESSMENT, PROCESS) - what is done for the patient diagnostically and therapeutically.Cohort Studies: Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.Treatment Failure: A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.Survival Analysis: A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Combined Modality Therapy: The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.Survival Rate: The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.Severity of Illness Index: Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.Recurrence: The return of a sign, symptom, or disease after a remission.Predictive Value of Tests: In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.Patient Compliance: Voluntary cooperation of the patient in following a prescribed regimen.Extensively Drug-Resistant Tuberculosis: Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.Tuberculosis, Multidrug-Resistant: Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.Randomized Controlled Trials as Topic: Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.Buprenorphine: A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.Multivariate Analysis: A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.Kaplan-Meier Estimate: A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)Opioid-Related Disorders: Disorders related or resulting from abuse or mis-use of opioids.Substance-Related Disorders: Disorders related to substance abuse.Psychotherapy: A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication.Substance Abuse Treatment Centers: Health facilities providing therapy and/or rehabilitation for substance-dependent individuals. Methadone distribution centers are included.Quality of Life: A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).Logistic Models: Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.Alcoholism: A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)Infant, Newborn: An infant during the first month after birth.Drug Therapy, Combination: Therapy with two or more separate preparations given for a combined effect.Age Factors: Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.Hospitals, Chronic Disease: Hospitals which provide care to patients with long-term illnesses.Neoplasm Staging: Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM.Temperance: Habitual moderation in the indulgence of a natural appetite, especially but not exclusively the consumption of alcohol.Antineoplastic Combined Chemotherapy Protocols: The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.Risk Assessment: The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)Patient Satisfaction: The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial.Psychiatric Status Rating Scales: Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.United StatesRemission Induction: Therapeutic act or process that initiates a response to a complete or partial remission level.Patient Dropouts: Discontinuance of care received by patient(s) due to reasons other than full recovery from the disease.Implosive Therapy: A method for extinguishing anxiety by a saturation exposure to the feared stimulus situation or its substitute.Cocaine-Related Disorders: Disorders related or resulting from use of cocaine.Disease-Free Survival: Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)Depressive Disorder, Major: Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.Longitudinal Studies: Studies in which variables relating to an individual or group of individuals are assessed over a period of time.Residential Treatment: A specialized residential treatment program for behavior disorders including substance abuse. It may include therapeutically planned group living and learning situations including teaching of adaptive skills to help patient functioning in the community. (From Kahn, A. P. and Fawcett, J. Encyclopedia of Mental Health, 1993, p320.)Retreatment: The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.Clinical Trials as Topic: Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.Proportional Hazards Models: Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.Regression Analysis: Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.Reproducibility of Results: The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.Anti-Retroviral Agents: Agents used to treat RETROVIRIDAE INFECTIONS.Chi-Square Distribution: A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.Genotype: The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.Coinfection: Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.Incidence: The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.Ethambutol: An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863)Behavior Therapy: The application of modern theories of learning and conditioning in the treatment of behavior disorders.Medication Adherence: Voluntary cooperation of the patient in taking drugs or medicine as prescribed. This includes timing, dosage, and frequency.Anti-HIV Agents: Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.Neoplasm Recurrence, Local: The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.Disease Progression: The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.Research Design: A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.Analysis of Variance: A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.Ribavirin: A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.Patient Selection: Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.Sex Factors: Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.Opiate Substitution Treatment: Medical treatment for opioid dependence using a substitute opiate such as METHADONE or BUPRENORPHINE.Antidepressive Agents: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.Peer Review, Health Care: The concurrent or retrospective review by practicing physicians or other health professionals of the quality and efficiency of patient care practices or services ordered or performed by other physicians or other health professionals (From The Facts On File Dictionary of Health Care Management, 1988).Pharmacogenetics: A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).Narcotic Antagonists: Agents inhibiting the effect of narcotics on the central nervous system.Registries: The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers.Acute Disease: Disease having a short and relatively severe course.Length of Stay: The period of confinement of a patient to a hospital or other health facility.Recovery of Function: A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma.Glasgow Outcome Scale: A scale that assesses the outcome of serious craniocerebral injuries, based on the level of regained social functioning.Pilot Projects: Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work.Motivation: Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli.Orthodontics, Corrective: The phase of orthodontics concerned with the correction of malocclusion with proper appliances and prevention of its sequelae (Jablonski's Illus. Dictionary of Dentistry).Fertilization in Vitro: An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro.Statistics, Nonparametric: A class of statistical methods applicable to a large set of probability distributions used to test for correlation, location, independence, etc. In most nonparametric statistical tests, the original scores or observations are replaced by another variable containing less information. An important class of nonparametric tests employs the ordinal properties of the data. Another class of tests uses information about whether an observation is above or below some fixed value such as the median, and a third class is based on the frequency of the occurrence of runs in the data. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1284; Corsini, Concise Encyclopedia of Psychology, 1987, p764-5)Antineoplastic Agents: Substances that inhibit or prevent the proliferation of NEOPLASMS.Pain Measurement: Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.Depression: Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.Radiotherapy Dosage: The total amount of radiation absorbed by tissues as a result of radiotherapy.Desensitization, Psychologic: A behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli.Cost-Benefit Analysis: A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.Antiviral Agents: Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.Biological Markers: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.Double-Blind Method: A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.Ambulatory Care: Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility.Diagnosis, Dual (Psychiatry): The co-existence of a substance abuse disorder with a psychiatric disorder. The diagnostic principle is based on the fact that it has been found often that chemically dependent patients also have psychiatric problems of various degrees of severity.Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)Pregnancy Rate: The ratio of the number of conceptions (CONCEPTION) including LIVE BIRTH; STILLBIRTH; and fetal losses, to the mean number of females of reproductive age in a population during a set time period.Odds Ratio: The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.IndiaMagnetic Resonance Imaging: Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.Georgia (Republic)Prevalence: The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.Anti-Bacterial Agents: Substances that reduce the growth or reproduction of BACTERIA.Pyrazinamide: A pyrazine that is used therapeutically as an antitubercular agent.Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.Pain Management: A form of therapy that employs a coordinated and interdisciplinary approach for easing the suffering and improving the quality of life of those experiencing pain.Nose Neoplasms: Tumors or cancer of the NOSE.Orthodontics: A dental specialty concerned with the prevention and correction of dental and oral anomalies (malocclusion).CD4 Lymphocyte Count: The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.Alcohol Deterrents: Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism.Hospitalization: The confinement of a patient in a hospital.Clinical Protocols: Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy.Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.Cross-Sectional Studies: Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.Tomography, X-Ray Computed: Tomography using x-ray transmission and a computer algorithm to reconstruct the image.Disability Evaluation: Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits.Sertraline: A selective serotonin uptake inhibitor that is used in the treatment of depression.Antidepressive Agents, Second-Generation: A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.Antiretroviral Therapy, Highly Active: Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.Heroin Dependence: Strong dependence, both physiological and emotional, upon heroin.Vincristine: An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.)Socioeconomic Factors: Social and economic factors that characterize the individual or group within the social structure.Professional-Patient Relations: Interactions between health personnel and patients.Demography: Statistical interpretation and description of a population with reference to distribution, composition, or structure.Anxiety Disorders: Persistent and disabling ANXIETY.Uganda: A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala.Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.Multicenter Studies as Topic: Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.Linear Models: Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.Antibiotics, Antitubercular: Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.Mycobacterium tuberculosis: A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.Esthetics: The branch of philosophy dealing with the nature of the beautiful. It includes beauty, esthetic experience, esthetic judgment, esthetic aspects of medicine, etc.Questionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Rifampin: A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)Anxiety: Feeling or emotion of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.South Africa: A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria (administrative), Cape Town (legislative), and Bloemfontein (judicial). Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960.Psychometrics: Assessment of psychological variables by the application of mathematical procedures.Patient Outcome AssessmentFamily Therapy: A form of group psychotherapy. It involves treatment of more than one member of the family simultaneously in the same session.Naltrexone: Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.Evidence-Based Medicine: An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006)Drug Combinations: Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.Breast Neoplasms: Tumors or cancer of the human BREAST.Health Status: The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures.Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.Chemoradiotherapy: Treatment that combines chemotherapy with radiotherapy.Tumor Markers, Biological: Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.Citalopram: A furancarbonitrile that is one of the SEROTONIN UPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition.Case-Control Studies: Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.Serotonin Uptake Inhibitors: Compounds that specifically inhibit the reuptake of serotonin in the brain.Viral Load: The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.Doxorubicin: Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.Great BritainNasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.Endometrial Ablation Techniques: Procedures used for the targeted destruction of the mucous membrane lining of the uterine cavity.Smoking Cessation: Discontinuation of the habit of smoking, the inhaling and exhaling of tobacco smoke.Confidence Intervals: A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable.Lung Neoplasms: Tumors or cancer of the LUNG.Comorbidity: The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.Reoperation: A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.Chemotherapy, Adjuvant: Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.Single-Blind Method: A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned.Malawi: A republic in southern Africa east of ZAMBIA and MOZAMBIQUE. Its capital is Lilongwe. It was formerly called Nyasaland.Dental Models: Presentation devices used for patient education and technique training in dentistry.Radiotherapy, Adjuvant: Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.Marijuana Abuse: The excessive use of marijuana with associated psychological symptoms and impairment in social or occupational functioning.Ethionamide: A second-line antitubercular agent that inhibits mycolic acid synthesis.Data Interpretation, Statistical: Application of statistical procedures to analyze specific observed or assumed facts from a particular study.Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.Infertility, Female: Diminished or absent ability of a female to achieve conception.Episode of Care: An interval of care by a health care facility or provider for a specific medical problem or condition. It may be continuous or it may consist of a series of intervals marked by one or more brief separations from care, and can also identify the sequence of care (e.g., emergency, inpatient, outpatient), thus serving as one measure of health care provided.Countertransference (Psychology): Conscious or unconscious emotional reaction of the therapist to the patient which may interfere with treatment. (APA, Thesaurus of Psychological Index Terms, 8th ed.)Activities of Daily Living: The performance of the basic activities of self care, such as dressing, ambulation, or eating.Hospital Mortality: A vital statistic measuring or recording the rate of death from any cause in hospitalized populations.Interferon-alpha: One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.Cyclophosphamide: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.Thailand: Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city.Outpatients: Persons who receive ambulatory care at an outpatient department or clinic without room and board being provided.Visual Acuity: Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.Antimalarials: Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)Polyethylene Glycols: Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.Forecasting: The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology.Radiotherapy: The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.Drug Resistance, Multiple, Bacterial: The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).Mandibular Advancement: Moving a retruded mandible forward to a normal position. It is commonly performed for malocclusion and retrognathia. (From Jablonski's Dictionary of Dentistry, 1992)

*  Running Injury Clinic | Optimal rehabilitation protocols for the treatment of...
Outcome variables will be collected from each subject at baseline and one time per week ... PFPS patients will be randomly assigned to a treatment protocol: (T1) a hip and core ... The purpose of this outcome-based, single-blinded, RCT investigation is to 1) compare a ... Home , Research , Optimal rehabilitation protocols for the treatment of patellofemoral ......
http://runninginjuryclinic.com/research/optimal-rehabilitation-protocols-for-the-treatment-of-patellofemoral-pain-syndrome-an-outcome-based-rct-multi-centered-study/
*  Does HIV status affect the aetiology, bacterial resistance patterns and...
Treatment outcomes. Overall mortality was 21.5% (97/452). As can be seen in Table 5, ... Table 5. Treatment outcome of 452 episodes of bloodstream infection according to HIV ... for the treatment of melioidosis) and vancomycin (i.e. for treatment of invasive MRSA ... Appropriateness of empiric antibiotic treatment and subsequent treatment changes. Overall ......
http://onlinelibrary.wiley.com/doi/10.1111/tmi.12060/full?globalMessage=0
*  JCI - Outcomes of acute leukemia patients transplanted with naive T cell...
Patients and treatment. Thirty-five patients, aged 19 to 55 years, with AML, ALL, or ... Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as ... Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell ... The contrasting GVHD outcomes observed may initially appear unexpected but are actually ......
http://jci.org/articles/view/81229
*  Prescription Opioid Epidemic and Infant Outcomes | Articles | Pediatrics
Patient characteristics associated with buprenorphine/naloxone treatment outcome for ... Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J ... Methadone and perinatal outcomes: a prospective cohort study. Addiction. 2012;107(8):1482 ... Outcome. Infants with NAS were identified if the ICD-9-CM code 779.5 (drug withdrawal ......
http://pediatrics.aappublications.org/content/135/5/842?sid=b83eef1f-e751-4c22-90cc-26038babcf36
*  Harms from breast cancer screening outweigh benefits if death caused by...
Harms from breast cancer screening outweigh benefits if death caused by treatment is ... the Marmot committee chose to duck that one and rely on another surrogate outcome measure ... Harms from breast cancer screening outweigh benefits if death caused by treatment is ... Harms from breast cancer screening outweigh benefits if death caused by treatment is ......
http://bmj.com/content/346/bmj.f385
*  CiNii 論文 - Clinicopathologic study of nasal T...
Treatment outcome and prognostic factors for primary nasal lymphoma LIANG R. J Clin Oncol ... Treatment of granulomatous disorders of the nose and paranasal sinuses ANDRASSY K. ... Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord ... Successful Treatment of Disseminated Nasal NK/T-Cell Lymphoma Using Double Autologous ......
http://ci.nii.ac.jp/naid/10008336937
*  Early intervention dramatically improves outcomes for new dialysi... ( ...
... outcomes,for,new,dialysis,patients,medicine,medical news today,latest medical news, ... This information can be used to develop patient-specific treatment ... The two salivary ... Outcomes were compared with those of 1,020 new dialysis patients at clinics not using the ... "This program for new patients has shown itself to dramatically improve outcomes, when ......
http://bio-medicine.org/medicine-news-1/Early-intervention-dramatically-improves-outcomes-for-new-dialysis-patients-4034-1/
*  Plus it
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med ... Bevier WC, Fischer R, Jovanovic L: Treatment of women with an abnormal glucose challenge ... Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. ... Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991-2002, 2008. ......
http://care.diabetesjournals.org/content/31/10/2026
*  Narcotics Anonymous Jersey City NJ - narcotics anonymous, Jersey City NJ ...
Significantly improved medical outcomes. Reduced treatment disruptions. Elimination of ... Treatment for Compulsive Gambling Addictions Jersey City NJ Treatment for Children and ... Treatment for Eating Disorders Jersey City NJ Treatment for Eating Disorders in Jersey ... Services Offered: Substance abuse treatment. Residency: Residential long-term treatment ( ......
http://articles.directorym.com/Narcotics_Anonymous_Jersey_City_NJ-p1775194-Jersey_City_NJ.html
*  Clinical trial seeks to improve patient treatment for Crohn ... ( Robarts...
... treatment,for,Crohn s,disease,medicine,medical news today,latest medical news,medical ... The outcome is expected to lead to a more streamlined treatment path and better disease ... Clinical trial seeks to improve patient treatment for Crohn s disease. ...Robarts ... 3, 2017 Opioid addiction and other ... up healthcare costs and threatening outcomes, were ......
http://bio-medicine.org/medicine-news-1/Clinical-trial-seeks-to-improve-patient-treatment-for-Crohn-26-23146-3Bs-disease-64156-1/
*  National Drug Strategy - 7.8 Major clinical issues with psychosis and inhalent/ solvent use
Home Publications Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician 7.8 Major clinical issues with psychosis and inhalent/ solvent use prev page. 5.3 Major clinical issues with depression and cannabis/ hallucinogen use. 5.6 Major clinical issues with depression and stimulant including methamphetamine use. 5.8 Major clinical issues with depression and inhalant/ solvent use 6. 6.3 Major clinical issues with anxiety disorders and cannabis/ hallucinogen use. 6.4 Major clinical issues with anxiety disorders and alcohol use. 6.6 Major clinical issues with anxiety disorders and stimulant including methamphetamine use. 6.8 Major clinical issues with anxiety disorders and inhalent/ solvent use 7. 7.3 Major clinical issues with psychosis and cannabis/ hallucinogen use. 7.8 Major clinical issues with psychosis and inhalent/ solvent use 8. 8.6 Major clinical issues with personality disorders and stimulant including methamphetamine use. 9.3 Major clinical issues with eating di...
http://nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/mono71-toc~mono71-7~mono71-7-8
*  New radiotracer shows early treatment response for patients with lung cancer | Cancer Network
New radiotracer shows early treatment response for patients with lung cancer. Cancer Network SearchMedica. Topics: ARS 2015. Breast Cancer. Colorectal Cancer. Lung Cancer. Prostate Cancer. Browse All Topics All Topics ARS 2015 Breast Cancer Colorectal Cancer Leukemia & Lymphoma Lung Cancer Melanoma Prostate Cancer. Cancer Network SearchMedica. Topics: ARS 2015. Breast Cancer. Colorectal Cancer. Lung Cancer. Prostate Cancer. Browse All Topics All Topics ARS 2015 Breast Cancer Colorectal Cancer Leukemia & Lymphoma Lung Cancer Melanoma Prostate Cancer. New radiotracer shows early treatment response for patients with lung cancer. New radiotracer shows early treatment response for patients with lung cancer. In all patients, baseline lesion uptake of F-FLT on PET/CT was concordant with the staging FDG PET/CT. The maximum standard uptake value SUVmax of the primary tumor was on average 2.2 times greater on baseline F-FDG scans than on baseline F-FLT scans. F-FLT uptake in tumors was observed on five of nine on-treat...
http://cancernetwork.com/lung-cancer/new-radiotracer-shows-early-treatment-response-patients-lung-cancer
*  An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer - Tabular View - Cl
... inicalTrials.gov. National Institutes of Health Example: "Heart attack" AND "Los Angeles" Search for studies:. Find Studies. How to Find Results of Studies. Submit Studies. RSS Feeds. Find Studies Study Record Detail. An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer This study has been completed. Sponsor: Epimmune Information provided by: Epimmune. ClinicalTrials.gov Identifier: NCT00054912 First received: February 12, 2003 Last updated: April 7, 2008 Last verified: April 2004 History of Changes. Primary Completion Date Not Provided. Current Primary Outcome Measures ICMJE. Not Provided. Original Primary Outcome Measures ICMJE. Not Provided. Complete list of historical versions of study NCT00054912 on ClinicalTrials.gov Archive Site. Current Secondary Outcome Measures ICMJE. Not Provided. Original Secondary Outcome Measures ICMJE. Not Provided. Current Other Outcome Measures ICMJE. Not Provided. Original Other Outcome Measures ICMJE. Not Provided. An Open Label Study of a Pe...
https://clinicaltrials.gov/ct2/show/record/NCT00054912
*  Diabetes Linked With Worse Long-Term Outcomes Following Heart Surgery | STS
Diabetes Linked With Worse Long-Term Outcomes Following Heart Surgery. STS. Skip to Content Skip to Navigation. Login. Diabetes Linked With Worse Long-Term Outcomes Following Heart Surgery. Increasing incidence of diabetes presents global clinical and economic challenges Chicago – Patients with diabetes mellitus have worse long-term outcomes and higher associated costs following coronary artery bypass grafting CABG surgery than patients without diabetes, according to a study in the June 2014 issue of The Annals of Thoracic Surgery. Although the study was conducted at a single institution in Beijing, China, the increasing prevalence of diabetes is a growing problem worldwide that has many health care professionals concerned. “In China, nearly 114 million adults 11.6% have diabetes,” said lead study author Heng Zhang, MD, from Fuwai Hospital. “In the United States, the rate is nearly the same at 11.3% or about 25.6 million adults.” Diabetes is a major cause of heart disease and stroke and is the 7th leading cau...
http://sts.org/news/diabetes-linked-worse-long-term-outcomes-following-heart-surgery
*  Undiagnosed "diarrhea" type issue, need help with possible treatments/solutions
Undiagnosed diarrhea type issue, need help with possible treatments/solutions. . Horse Forums. Horses. Equine Vets. Horse Gifts. The Horse Forum. Keeping and Caring for Horses. Horse Health. Undiagnosed diarrhea type issue, need help with possible treatments/solutions. User Name. Remember Me. Password. Register Horses FAQ Calendar Search Today's Posts Mark Forums Read. Undiagnosed diarrhea type issue, need help with possible treatments/solutions This is a discussion on Undiagnosed diarrhea type issue, need help with possible treatments/solutions within the Horse Health forums, part of the Keeping and Caring for Horses category What do i use if my mare has diarrhea Shetlands with diahria. Page 1 of 2 1 2. LinkBack Thread Tools. 09-30-2011, 12:59 PM. # 1. Surr. User. Horses. Foal. Undiagnosed diarrhea type issue, need help with possible treatments/solutions I have never used a forum before, but I am becoming nearly desperate to figure out what my horses condition is. Numerous vets, experienced horse people, etc...
http://horseforum.com/horse-health/undiagnosed-diarrhea-type-issue-need-help-99287/
*  Moving sensor: an attractive option?
Moving sensor: an attractive option. Welcome, Guest. Please login or register. CanonRumors. Forum Home. Help. Search. Login. Register. October 06, 2015, 11:01:05 PM. canon rumors FORUM. Rumors. EOS Bodies. Moving sensor: an attractive option. previous next Print. Pages:. Author Topic: Moving sensor: an attractive option. Read 1267 times. scottburgess EOS M2. Posts: 155 Canonical Canon. . Moving sensor: an attractive option. on: February 15, 2014, 04:35:11 PM. Suppose Canon executes a technology exchange with Hasselblad for this technology: http://news.cnet.com/8301-30685 3-20066021-264.html Would you be interesting in having this as an option on your camera body, despite the long exposure times. What cost limit would you put for adding in this feature. Logged. canon rumors FORUM. Moving sensor: an attractive option. on: February 15, 2014, 04:35:11 PM. noisejammer EOS M2. Posts: 181. . Re: Moving sensor: an attractive option. Reply #1 on: February 15, 2014, 05:19:38 PM. Interesting application but dithering ha...
http://canonrumors.com/forum/index.php?topic=19613.msg369324;topicseen
*  course listing | fxphd
VFX. MOGRAPH. VUE. standard course 3D mograph. get full course details. standard course 3D mograph. get full course details. new standard course 3D mograph. get full course details. new standard course 3D vfx. get full course details. new standard course vfx. get full course details. get full course details. get full course details. get full course details. standard course vfx. get full course details. standard course vfx. get full course details. new standard course vfx. get full course details. get full course details. Tornado Destruction Project, Part 1 Course Number: VFX301 Professor: Ludovic Iochem Primary Software: Maya. standard course vfx. get full course details. The Underwater Shot Course Number: VFX303 Professor: Ludovic Iochem Primary Software: Nuke. new standard course 3D vfx. get full course details. new standard course vfx. get full course details. standard course vfx production. get full course details. standard course vfx production. get full course details. After Effects: Project A to Z Cour...
https://fxphd.com/fxphd/courseInfo.php
*  First Line Therapy for Patients With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov
... First Line Therapy for Patients With Metastatic Breast Cancer This study has been terminated. Participants who initiated other anticancer therapy prior to progression were censored at the time when new anticancer therapy was initiated. as the time between the start of a complete response CR or partial response PR and the start of progressive disease PD or patient death from any cause, whichever occurred first. Participants who had initiated other anticancer therapy prior to progression were censored at the time when new anticancer therapy was initiated. as the time between the start of a complete response CR or partial response PR and the start of progressive disease PD or patient death from any cause, whichever occurred first. Participants who had initiated other anticancer therapy prior to progression were censored at the time when new anticancer therapy was initiated. No prior chemotherapy for metastatic breast cancer At least 12 months between completion of adjuvant chemotherapy and the diagnosis of ...
https://clinicaltrials.gov/ct2/show/NCT00456846
*  A Randomized, Controlled, Open Label Trial Comparing the Ischemic Preconditioning Effects of Ticagre
... lor and Clopidogrel in Humans - Find a Clinical Trial - UT Southwestern. Medical School. Graduate School. School of Health Professions. Medical School You and the Future of Medicine Admissions. School of Health Professions Doctorate. Center for Translational Medicine. Find a Clinical Trial. Scientific Discoveries. Request an Appointment. Google +1 Close This Window Email This Page This is an error This is success Your Name: required Your Email: required Recipient Name: required Recipient Email: required Personal Message: optional Please be patient while your page is being shared. UT Southwestern-Clinical Translational Research Center CTRC Clements University Hospital Dallas Veteran's Affairs Medical Center Parkland Health & Hospital System. Summary We propose a prospective, randomized open label trial that will randomize 30 patients undergoing clinically-indicated coronary angiography, and found to have single or two or three vessel coronary artery disease, to clopidogrel 600 mg loading dose, 75 mg daily ...
http://utsouthwestern.edu/research/fact/detail.html?studyid=STU 122012-033
*  Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy i
... n extremity soft tissue sarcoma. Bone Cancers. Gynecologic Cancers. Skin Cancers. Cancer Treatment. OncoLink University. Find My Cancer Drug A B C D E F G H. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma Reviewer: John Wilson, MD Abramson Cancer Center of the University of Pennsylvania Last Modified: March 26, 2006. Late subcutaneous fibrosis and joint stiffness were assessed using the joint EORTC/RTOG late toxicity scoring criteria. Authors' Conclusions The authors report that these results suggest that postop RT causes more late toxicity, but they admit the toxicity is not significantly different from that seen with preop RT. However, they do point out that the sample size was fairly underpowered to show a difference in late toxicity, with powers of 40% for fibrosis, 12% for joint stiffness, and 22% for extremity edema. They conclude by saying that preop RT may have less late toxicity, but this must be balanced against...
https://oncolink.org/library/article1.cfm?id=818&c=174
*  Stem cell gene expression programs influence clinical outcome in human leukemia. | Broad Institute o
Stem cell gene expression programs influence clinical outcome in human leukemia. Broad Institute of MIT and Harvard. Partnerships Philanthropy Careers Contact Us. What is Broad. Our Approach Areas of Focus History Leadership Who is Broad Partner Institutions Artist-in-Residence Media Center. Press Room News from the Broad Photos for Journalists Spotlight: Ebola Spotlight: CRISPR BroadMinded Blog Video Library For the Scientific Community. Scientific Publications Science Data Software. Scientific Publications Science Data Software. Home. News & Publications:Scientific Publications Stem cell gene expression programs influence clinical outcome in human leukemia. Recent Broad Publications Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease. Read More / View Supplemental Materials Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Read More ...
http://broadinstitute.org/publications/broad3127
*  Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Org
... an Transplant Recipients - sberg - 2010 - American Journal of Transplantation - Wiley Online Library. Skip to Main Content. Log in / Register. Log In. E-Mail Address. Password. Forgotten Password. Remember Me. Register. Institutional Login. Home. Transplantation. Transplantation. American Journal of Transplantation. Vol 10 Issue 8. Abstract. JOURNAL TOOLS Get New Content Alerts. Get RSS feed. Save to My Profile. Get Sample Copy. Recommend to Your Librarian. JOURNAL MENU Journal Home FIND ISSUES Current Issue. All Issues. Virtual Issues FIND ARTICLES Early View. Reviews. Most Accessed. Most Cited. GET ACCESS Subscribe / Renew. FOR CONTRIBUTORS OnlineOpen. Author Guidelines. Submit an Article. ABOUT THIS JOURNAL Society Information. News. Overview. Editorial Board. Permissions. Advertise. Contact. SPECIAL FEATURES The AJT Report. Literature Watch. Reports From the CDC: MMWR. Images in Transplantation. AJT Video Library. Cover Gallery. Reviewer Thank You. AJT App. AJT in the Press. AJT on Twitter. You have f...
http://onlinelibrary.wiley.com/doi/10.1111/j.1600-6143.2010.03114.x/abstract
*  wireshark-dev Re: [Wireshark-dev] Possible New Option for Tshark? wireshark-dev: Re: [Wireshark-dev
wireshark-dev Re: Possible New Option for Tshark. wireshark-dev: Re: Possible New Option for Tshar. Re: Possible New Option for Tshark. This message: Related messages: buildbot failure in Wireshark development on Windows-7-x64 ">Next message ] Seg Fault - Creating new wiretap type - RESOLVED ">Previous message ] Possible New Option for Tshark. ">In reply to ] Possible New Option for Tshark. Date: Sun Oct 24 2010 - 14:33:57 GMT To: Developer support list for Wireshark wireshark-dev@wireshark. org. Save your packets in a temp pcap file and pass the file name to your tshark child process when you are spawning it. When tshark finishes reading all the packets in your temp file and writes all the dissection data to wherever you are sending it assuming a pipe, tshark will close and your read will stop blocking. If you want to dissect more packets later on, just respawn another tshark child process. On Thu, Oct 21, 2010 at 03:29:36PM -0500, Craig Votava wrote:. How about using pdml or psml with the -T option....
http://engardelinux.org/modules/index/list_archives.cgi?list=wireshark-dev&page=0291.html&month=2010-10
*  Single stage recommendations - Hot Rod Forum : Hotrodders Bulletin Board
... Today's Posts. Unanswered Posts. Body-Exterior. Garage-Tools. Tools. Garage. Body-Exterior. Wiki. Body and Exterior. Tools. Photo Journals. Body-Exterior Parts. all of Hotrodders.com Forums Project Journals Knowledge Base Wiki Articles Photos Classifieds Company Reviews. Register FAQ Search Today's Posts Unanswered Posts Auto Escrow Insurance Auto Loans. Body - Exterior. Single stage recommendations. Join us, it's free. User Name. Password. lost password. LinkBack Thread Tools. permalink 06-01-2006, 05:00 AM. kaw550. Registered User. Last photo:. Join Date: Jun 2006 Location: MA Posts: 111 Wiki Edits: 0. Thanks: 0 Thanked 0 Times in 0 Posts. kaw550's Photo Album. Single stage recommendations I am trying to choose a single stage paint that is relatively easy to apply, safe to apply at home and look good. permalink 06-01-2006, 05:17 AM. Last photo:. Join Date: Oct 2002 Location: Newport News, VA Posts: 3,220 Wiki Edits: 0. Thanks: 0 Thanked 0 Times in 0 Posts. adtkart's Photo Album. Using a single stage pa...
http://hotrodders.com/forum/single-stage-recommendations-90757.html
*  Chapter 1 Required Surveys for Impact Outcome Evaluation
... Turn on more accessible mode. Turn off more accessible mode. Skip to: Content. Footer. Accessibility This site California. Home. Programs. Services. Health Information. Certificates Licenses. Publications Forms. Data. Take the CDPH Website Survey. en Español. Su salud en su idioma. Most Popular Links. Birth, Death, Marriage Certificates. Licensing and Certification. WIC. Quick Links. About Us. CDPH Open Data Portal. Decisions Pending Opportunities for Public Participation. Diseases Conditions. Job Opportunities. Language Access Complaint Process. Local Health Services. Newsroom. Public Availability of Documents. Related Links. California Health and Human Services Agency. Department of Health Care Services includes Medi-Cal. State Agencies Directory. Home. Programs. Cancer Prevention and Nutrition Section. Chapter 1 Required Surveys for Impact Outcome Evaluation. Chapter 1 Required Surveys for Impact Outcome Evaluation The tools summarized in this chapter are required surveys for local Nutrition Education...
http://cdph.ca.gov/programs/cpns/Pages/Chapter1RequiredSurveysforImpactOutcomeEvaluation.aspx
*  Possible treatment for kidney disease in lupus stu... (ules and selected this inhibitor which s...)
Cached Biology News: Study shows that suffocating head lice works in new treatment 2 78 scientists elected to the American Academy of Microbiology 2 78 scientists elected to the American Academy of Microbiology 3 78 scientists elected to the American Academy of Microbiology 4 USC chosen for $25 million NSF center 2 USC chosen for $25 million NSF center 3. Breaking Biology Technology: xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2 Oramed to Present at the Aegis Capital Growth Conference 2 Oramed to Present at the Aegis Capital Growth Conference 3 The Masonry Heater Association of North America Receives News About A New York Couple Who Saved Considerable Money Heating Their Home With A Wood Fired Masonry Heater 2 Resverlogix Announces Voting Results 2. Cached Biology Technology: X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHI's Protein Engineering Summit 2 Neogen launches the fastest molecular pathogen test 2 Upshe...
http://bio-medicine.org/biology-news-1/Possible-treatment-for-kidney-disease-in-lupus-studied-at-UH-35491-3/
*  Surgical Treatment Provides New Option for Some Colorectal Cancer Patients
... Wake Forest Baptist Medical Center Careers. Employees. Media. Contact. myWakeHealth I Want To: Find a Doctor Request an Appointment Find a Location Log In to myWakeHealth Pay My Bill Participate in a Clinical Trial Support Wake Forest Baptist. Patients Visitors. Referring Physicians. Research. Education. About Us. Innovations. Community Benefits. Health Needs Assessment. Community Relations. Leadership. Board. Medical Center Firsts. Gray Family History. Mission, Vision Values. Key Dates. Financial Statement. Quality and Awards. Volunteer Services. Adults. College Students. High School Seniors. Teens. News Media. Download the Fact Book. Media Contacts. Medical Experts for the News Media. News Releases. Patient Information. Photos, Video Audio. TV Studio Satellite Uplink. Download Center. Brand Center. Giving to WFBMC. Departments. About Us > News Media > News Releases > 2008. Surgical Treatment Provides New Option for Some Colorectal Cancer Patients. Tweet. Print Email rss. WINSTON-SALEM, N.C. – Research ...
http://wakehealth.edu/News-Releases/2008/Surgical_Treatment_Provides_New_Option_for_Some_Colorectal_Cancer_Patients.htm
*  Short-term Endocrine Therapy Prior to and During Radiation Therapy Improves Overall Survival in Pati
... ents with T1b – T2b Adenocarcinomas of the Prostate and PSA. Cancer Types. Cancer Types. Short-term Endocrine Therapy Prior to and During Radiation Therapy Improves Overall Survival in Patients with T1b – T2b Adenocarcinomas of the Prostate and PSA. Multiple studies have demonstrated that patients with high- and intermediate-risk disease may achieve improved biochemical failure-free survival, disease specific survival, and overall survival with addition of androgen ablation treatment to radiation. Ten-year overall survival was 62% in the group receiving androgen ablation treatment, and 57% in the group not, with a hazard ratio for death in the radiotherapy alone group of 1.17 p = 0.03. Ten-year disease specific survival was 96% in the group receiving androgen ablation, versus 93% in the radiotherapy alone group p 0.01, with a hazard ratio of 1.84. Overall survival, disease specific survival, and biochemical failure free survival were impacted most significantly by the addition of androgen ablation in the ...
http://oncolink.org/conferences/article.cfm?c=3&s=60&ss=297&id=1972
*  Surgical Procedures and Outcomes
... Sub-cluster of Surgical Procedures and Outcomes From the advanced search, you can use the IDs below to search within the topic " Surgical Procedures and Outcomes " whose ID is 16, by searching on 16/0 replacing the "16/0" with any cluster id below. Surgical Procedures and Outcomes sub-cluster 0. Surgical Procedures and Outcomes sub-cluster 1. Surgical Procedures and Outcomes sub-cluster 2. Surgical Procedures and Outcomes sub-cluster 3. Surgical Procedures and Outcomes sub-cluster 4. Surgical Procedures and Outcomes sub-cluster 5. lc cholecystectomy laparoscopic patients duct oc surgery bile cholecystitis postoperative. Surgical Procedures and Outcomes sub-cluster 6. Surgical Procedures and Outcomes sub-cluster 7. Surgical Procedures and Outcomes sub-cluster 8. Surgical Procedures and Outcomes sub-cluster 9. Surgical Procedures and Outcomes sub-cluster 10. Surgical Procedures and Outcomes sub-cluster 11. Surgical Procedures and Outcomes sub-cluster 12. Surgical Procedures and Outcomes sub-cluster 13. Sur...
http://biomedsearch.com/cluster/16/Surgical-Procedures-and-Outcomes/
*  Boston Therapeutics Inc To Initiate A Phase II Clinical Study Of BTI 320 In U S
... To Initiate A Phase II Clinical Study Of BTI-320 In U.S. OTCQB: BTHE "Boston Therapeutics" or "the Company", an innovative developer of compounds that address diabetes using complex carbohydrate chemistry, has received Institutional Review Board IRB approval to initiate a clinical study of BTI-320 previously named PAZ320 in the United States. The U.S.-based trial is intended to mirror the Company's study of BTI-320 currently enrolling patients in France. trial plans to enroll 24 patients with Type 2 diabetes who are currently being treated with metformin. Patients' blood glucose will be monitored and their postprandial after-meal blood glucose levels will be measured following a test meal. We believe it is important to better control glucose levels throughout the day, given the many complications that stem from uncontrolled diabetes." About BTI-320 BTI-320 is a non-systemic chewable complex carbohydrate-based compound designed to reduce post-meal elevation of blood glucose. The Company's product pipeline...
http://biospace.com/news_story.aspx?StoryID=325905
*  .. Monthly Archives: March 2014 .. What Are the Potential Side Effects of
Monthly Archives: March 2014 Post navigation. Newer posts → What Are the Potential Side Effects of Iron Therapy. Posted on. March 3, 2014. by. pediatriceducationmin. Patient Presentation A 15-month-old caucasian male came to clinic for his health supervision visit. He was developing and growing normally and his parents had no concerns. He was taking a mixed diet appropriate for his age with ~20 ounces of whole milk daily. The pertinent physical exam showed a healthy appearing male with growth parameters at the 75% and a normal examination. His screening laboratory evaluation showed a hemoglobin of 10.6 mg/dL. The new intern wasn’t sure how to manage the diagnosis of anemia and asked about how much iron to prescribe. His medical record review noted a normal neonatal screening test and normal complete blood count at birth done because of a maternal fever. After discussion with her attending physician, they decided that this presumably was iron deficiency anemia, and they would treat with supplemental iron for 1...
http://pediatriceducation.org/2014/03/page/2/
*  hivandhepatitis.com - EASL 2014: MK-5172 + MK-8742 Demonstrate Good Early Post-Treatment Response Ra
... tes. Experimental HCV Drugs EASL 2014: MK-5172 + MK-8742 Demonstrate Good Early Post-Treatment Response Rates. A combination of 2 direct-acting antivirals, MK-5172 and MK-8742, with or without ribavirin, led to early post-treatment sustained response rates above 90% for genotype 1 hepatitis C patients, including people with cirrhosis or HIV/HCV coinfection, according to a series of presentations last week at the 49th EASL International Liver Congress in London. In Part B, 30 genotype 1a patients were assigned to triple therapy for 8 weeks and 31 were assigned to ribavirin-free dual therapy for 12 weeks. Among participants treated for 12 weeks, 94% in the dual therapy arm and 98% in the triple therapy arm reached SVR4-SVR24. Looking at the treatment-naive cirrhotic group, with 4 to 8 weeks post-treatment follow-up, SVR4-SVR8 rates were 90% in the 12-week triple therapy arm with 1 viral breakthrough during treatment and 2 relapses, and 97% in the 12-week dual therapy arm and in both the 18-week arms. 97% in...
http://hivandhepatitis.com/hcv-treatment/experimental-hcv-drugs/4642-easl-2014-mk-5172-mk-8742-demonstrate-good-early-post-treatment-response-rates
*  Breathing Ladders to Instantly Improve Your Cardio - Pinkbike
... Breathing Ladders to Instantly Improve Your Cardio Feb 8, 2012 at 0:01 Feb 8, 2012. By learning how to drive your breathing from the diaphragm you can instantly improve the amount of oxygen you take in with each breathe as well as control how much carbon dioxide you exhale, resulting in improved cardio capacity without actually doing a single interval or training ride. In this video I show you how to check your breathing and also show you a cool kettlebell swing workout called Breathing Ladders that will help you train this important skill. Swing Breathing Ladder Begin at: 1 single arm swing +1 single arm = 1 breath for recovery 2 single arm swing +2 single arm swing = 2 breaths 3 single arm swing +3 single arm swing = 3 breaths 4 single arm swing +4 single arm swing = 4 breaths 5 single arm swing +5 single arm swing = 5 breaths 6 single arm swing +6 single arm swing = 6 breaths 7 single arm swing +7 single arm swing = 7 breaths 8 single arm swing +8 single arm swing = 8 breaths 9 single arm swing +9 sin...
http://pinkbike.com/news/Breathing-Ladders-to-Instantly-Improve-Your-Cardio-2012.html
*  - PROF.DR.ŞENGÜL ÖZDEK
We believe that, other parameters like visual acuity, presence of hemorrhage associated with the lesion, lesion size and FA staining pattern when needed are all also important for assessment of neovascular AMD activity. PARAMETER GRADING SCORE Hemorrhage Amount of hemorrhage associated with the lesion No hemorrhage 0 decreased 1 Same amount 2 increased 3 OCT Subretinal fluid / retinal thickening / PED None 0 Decreased 1 Any amount at beginning / Stable 2 Increased 3 Visual assessment Objective Increased 0 No change 1 Decreased 2 Visual assessment Subjective Increased 0 No change 1 Decreased 2 FA Staining pattern No staining/window defect 0 Staining of scar tissue/PED 1 Late leakage 2 Size of the lesion Lesion area in FA Decreased 0 Beginning size / Stable 1 Increased 2 Table 1: Clinical Activity Scoring for neovascular AMD lesions Apart from FA staining pattern, all of the other assessments are based on the changes same- baseline/increased/decreased in each parameter and given a number to define the activity....
http://sengulozdek.com/sar--nokta-hastal----.html
*  Randomized Phase III Trial of Radical Radiotherapy with Concurrent Carbogen and Nicotinamide in Loca
... lly-advanced Bladder Cancer. Cancer Types. Cancer Types. Randomized Phase III Trial of Radical Radiotherapy with Concurrent Carbogen and Nicotinamide in Locally-advanced Bladder Cancer Reviewer: Charles B. A recently published phase II trial demonstrated excellent local control of muscle invasive bladder transition cell carcinoma without a significant increase in acute or late treatment toxicity with this treatment combination. Among patients randomized to the RT+CN arm, compliance with nicotinamide was 70% and compliance with carbogen administration was 85%. Local relapse-free survival also trended high for patients in the RT+CN arm 74% versus 63%, p = 0.11. Disease-free survival and relapse-free survival were higher in the RT+CN arm but did not reach significance, possibly due to the study being underpowered. This study demonstrated an overall survival benefit without a significant benefit in local control for patients receiving carbogen and nicotinamide. As no chemotherapy was administered, the lack of...
http://oncolink.org/conferences/article.cfm?c=227&id=1973
*  Further Data on Stentys Self Apposing Stent Reinforces Strength of Clinical Results
... Employer:. Login. Post Jobs. Job Seeker:. Login. Sign Up. Home. News. Jobs. Career Resources. Hotbeds. Career Fairs. Events. Company Profiles. Investors. Search Life Sciences Jobs. Search Job Title Only. Radius: Miles. Km 80.5. News. News By Subject. News by Disease. News By Date. Search News. Get Our FREE Industry eNewsletter email:. Further Data on Stentys Self-Apposing Stent Reinforces Strength of Clinical Results. Tweet. 5/23/2013 8:45:07 AM Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today. PRINCETON, N.J. & PARIS, May 22, 2013 BUSINESS WIRE -- STENTYS FR0010949404 - STNT, a medical technology company commercializing in Europe the world's first and only Self-Apposing R Stent to treat acute myocardial infarction AMI, announced today new one-year data from the APPOSITION III clinical trial at the international EuroPCR conference in Paris. APPOSITION III was designed to assess the long-term performance of STENTYS Self-Apposing Stents in routine clinical practice ...
http://biospace.com/News/further-data-on-stentys-self-apposing-stent/297768
*  Study finds dramatic improvement in blood-sugar control among diabetes patients
... Click to Print. Study finds dramatic improvement in blood-sugar control among diabetes patients. NEW YORK Control of A1C, blood pressure and cholesterol among patients with diabetes has improved markedly, but more room for improvement remains, according to a new study. 15 issue of the journal Diabetes Care, found that from 1988 to 2010, the number of people with diabetes able to meet or exceed measures of A1C, blood pressure and cholesterol which together indicate good diabetes management rose from 2% to 19%. More than half of people met each individual goal in 2010. However, we see a lot of room for improvement for everyone, but particularly for younger people and some minority groups. According to 2007-2010 data, 53% of Americans with diabetes met A1C goals, compared with 43% in 1988-1994; 51% met blood pressure goals, compared with 33% in 1988-1994; and 56% met cholesterol goals, compared with 10% in 1988-1994. Nevertheless, blood glucose control was found to be worse among Mexican-Americans and young...
http://drugstorenews.com/print/525181?ad=regulatory-and-washington
*  Randomized Phase III Trial of Radical Radiotherapy with Concurrent Carbogen and Nicotinamide in Loca
... lly-advanced Bladder Cancer. Cancer Types. Cancer Types. Randomized Phase III Trial of Radical Radiotherapy with Concurrent Carbogen and Nicotinamide in Locally-advanced Bladder Cancer Reviewer: Charles B. A recently published phase II trial demonstrated excellent local control of muscle invasive bladder transition cell carcinoma without a significant increase in acute or late treatment toxicity with this treatment combination. Among patients randomized to the RT+CN arm, compliance with nicotinamide was 70% and compliance with carbogen administration was 85%. Local relapse-free survival also trended high for patients in the RT+CN arm 74% versus 63%, p = 0.11. This study demonstrated an overall survival benefit without a significant benefit in local control for patients receiving carbogen and nicotinamide. As no chemotherapy was administered, the lack of benefit in local control in patients treated with localized radiation therapy is unclear, particularly in light of a demonstrated survival benefit. Howeve...
http://oncolink.org/conferences/article1.cfm?id=1973
*  OncoLink - Abramson Cancer Center of the University of Pennsylvania
... Large Text Treatment after lumpectomy in small estrogen negative tumors Treatment after lumpectomy in small estrogen negative tumors Dear OncoLink "Ask The Experts," My wife has undergone a lumpectomy for a 0.8cm nodule, sentinel lymph nodes were clear. Is there as clear a course of therapy in these cases as there is for the er/pr positive patients. The first and most important treatment is surgical resection lumpectomy of the breast cancer which has been completed. However, the risk of local recurrence after a lumpectomy is quite high and radiation therapy to the breast is certainly indicated. A consultation with a radiation oncologist to discuss this therapy should be arranged for all patients after a lumpectomy. Most of the existing data assessing the benefit of chemotherapy is in patients with primary tumors larger than one centimeter. Of course, each patient's situation is assessed individually, but most women with a primary tumor that small do not gain a tremendous benefit from systemic chemotherap...
http://oncolink.org/includes/print_article.cfm?Page=2&id=2051§ion=ask_the_experts&aid=3017
*  The Firing Line Forums - View Single Post - Single Stage vs Turret press for beginners
... Thread : Single Stage vs Turret press for beginners View Single Post. Aguila Blanca Senior Member. Quote: Originally Posted by paulcissa Although you expect to turn out rounds faster via progressive, I'd caution about making your first press a multi-station/progressive. The Lee Turret Press or Classic Turret Press -- same thing with a cast iron base is NOT a progressive. It's somewhere between a single stage and a progressive, and it offers two ways to use it. The 4-hole Turret Press has auto-indexing. If you use that, the turret rotates 1/4 turn with each stroke of the handle, so you install a 4-die set and with four strokes of the handle you have loaded ONE round. For each pull of the handle, there is only one operation being performed, and three dies are doing nothing. On a progressive, something happens at each station on every pull. You can also remove the auto-index and run the Turret Press as a single stage -- the turret doesn't advance when you pull the handle. I'm another fan of the Lee Turret P...
http://thefiringline.com/forums/showpost.php?p=4608451&postcount=33
*  MRC Technology Enters Into an Exclusive License Agreement With... (business model.
Cached Biology Technology: X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHI's Protein Engineering Summit 2 Neogen launches the fastest molecular pathogen test 2 Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters 2 Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters 3 Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters 4 Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters 5. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHI's Protein Engineering Summit Neogen launches the fastest molecular pathogen test Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters...
http://bio-medicine.org/biology-technology-1/MRC-Technology-Enters-Into-an-Exclusive-License-Agreement-With-Genentech-16869-2/
*  Weak spot of parasitic worms attacked to cure tropica... ( Researchers are developing new drug ...)
Cached Biology News: Study shows that suffocating head lice works in new treatment 2 78 scientists elected to the American Academy of Microbiology 2 78 scientists elected to the American Academy of Microbiology 3 78 scientists elected to the American Academy of Microbiology 4 USC chosen for $25 million NSF center 2 USC chosen for $25 million NSF center 3. Breaking Biology Technology: xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2 Oramed to Present at the Aegis Capital Growth Conference 2 Oramed to Present at the Aegis Capital Growth Conference 3 The Masonry Heater Association of North America Receives News About A New York Couple Who Saved Considerable Money Heating Their Home With A Wood Fired Masonry Heater 2 Resverlogix Announces Voting Results 2. Cached Biology Technology: X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHI's Protein Engineering Summit 2 Neogen launches the fastest molecular pathogen test 2 Upshe...
http://bio-medicine.org/biology-news-1/Weak-spot-of-parasitic-worms-attacked-to-cure-tropical-diseases-34707-1/
*  Frost & Sullivan Recognizes TATAA Biocenter's Complete, Best-in-Class Services for Analyzing Geneti.
Cached Biology News: Study shows that suffocating head lice works in new treatment 2 78 scientists elected to the American Academy of Microbiology 2 78 scientists elected to the American Academy of Microbiology 3 78 scientists elected to the American Academy of Microbiology 4 USC chosen for $25 million NSF center 2 USC chosen for $25 million NSF center 3. Breaking Biology Technology: xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2 Oramed to Present at the Aegis Capital Growth Conference 2 Oramed to Present at the Aegis Capital Growth Conference 3 The Masonry Heater Association of North America Receives News About A New York Couple Who Saved Considerable Money Heating Their Home With A Wood Fired Masonry Heater 2 Resverlogix Announces Voting Results 2. Cached Biology Technology: X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHI's Protein Engineering Summit 2 Neogen launches the fastest molecular pathogen test 2 Upshe...
http://bio-medicine.org/biology-news-1/Frost--26amp-3B-Sullivan-Recognizes-TATAA-Biocenters-Complete--Best-in-Class-Services-for-Analyzing-Genetic-Material-31407-3/
*  Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies - Full Te
... xt View - ClinicalTrials.gov. Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies This study is currently recruiting participants. Primary Outcome Measures: Percentage of patients enrolled Percentage of patients in which long-term 20+ years contact is maintained Percentage of eligible patients located who were lost to follow-up Percentage of located patients enrolled Differences between participants and non-participants will be examined annually, in terms of demographic age, sex, ethnicity and clinical characteristics primary diagnosis, therapeutic protocol, time since diagnosis, treating institution. Patients are asked to complete a patient response form, verify information provided in packet, update contact information, and complete a Health Status Update Form. Other: Questionnaire Administration Complete patient response form and Health Status Update Form Procedure: Assessment of Therapy Complications Complete patient response form and Health Status Update Form. P...
https://clinicaltrials.gov/ct2/show/NCT00736749?term=Polycythemia Vera&recr=Open&fund=01&rank=15
*  Comparative Safety Study of New Sinecort Formulation Versus Positive Control - Tabular View - Clinic
... alTrials.gov. Comparative Safety Study of New Sinecort Formulation Versus Positive Control This study has been completed. Sponsor: Bayer Information provided by Responsible Party : Bayer. ClinicalTrials.gov Identifier: NCT00885937 First received: April 21, 2009 Last updated: June 20, 2014 Last verified: June 2014 History of Changes. Primary Completion Date May 2009 final data collection date for primary outcome measure. Current Primary Outcome Measures ICMJE submitted: April 21, 2009. Original Primary Outcome Measures ICMJE. Complete list of historical versions of study NCT00885937 on ClinicalTrials.gov Archive Site. Current Secondary Outcome Measures ICMJE submitted: April 21, 2009. Current Other Outcome Measures ICMJE. Not Provided. Original Other Outcome Measures ICMJE. Not Provided. Comparative Safety Study of New Sinecort Formulation Versus Positive Control. Single-blind, Randomized, Controlled, Single Center Trial to Evaluate the Skin Irritation Potential of a New Topical Formulation by Means of an ...
https://clinicaltrials.gov/ct2/show/record/NCT00885937
*  Herceptin Trials Usher in New Era in Adjuvant Therapy | Cancer Network
Breast Cancer. Breast Cancer. Breast Cancer. The joint analysis is on data from 3,351 patients: 1,736 women in NSABP-B31 and 1,615 women in NCCTG-N9831. In NSABP-B31, paclitaxel was given at 175 mg/m 2 every 3 weeks for four cycles; in NCCTG-N9831, paclitaxel was given at 80 mg/m 2 every week for 12 cycles. The study arm for the joint analysis, therefore, was AC followed by paclitaxel plus trastuzumab, and the control arm was AC followed by paclitaxel. Unprecedented Results Findings of the first interim intent-to-treat analysis of 395 DFS events were dramatic: Use of trastuzumab reduced the overall risk of local recurrence at 3 years by 52% hazard ratio = 0.48, 2P = 3 ´ 10 -12, with 261 recurrences in women on chemotherapy alone vs 134 in those on trastuzumab. The absolute reduction in risk of recurrence by Kaplan-Meier analysis was 12% with trastuzumab at 3 years, and 18% at 4 years. The estimated absolute reduction in risk with trastuzumab was 9% at 3 years and 16% at 4 years. Cardiac Risk While chemotherap...
http://cancernetwork.com/articles/herceptin-trials-usher-new-era-adjuvant-therapy
*  Neck Lift Hernia Doctor Answers, Q&A, Tips - RealSelf
... Warning: You do not have JavaScript enabled. Parts of this website will not display or function properly. For a better experience, please enable JavaScript. For Doctors Join Sign in. . Treatments. Video. Find a Doctor. Ask a Doctor. Write a Review. For Doctors. Sign In. Join. Search. Treatments. Neck Lift. Q A. Neck Lift Q A. Ask a doctor. Reviews 520. Pictures 1355. Videos 153. Q A 972. Forum 28. Guides. Cost. Hernia + Neck Lift. Narrow 1 question by:. All - Before or After Before After. All - Age age 17 or under age 18-24 age 25-34 age 35-44 age 45-54 age 55-64 age 65-74. All - Condition crepey skin double chin excess skin lines loose skin lumps neck bands pain sagging scar scarring swelling tightness turkey neck wrinkles. All - Post-Op 1 month post-op 1 week post-op 1 year post-op 11 months post-op 18 months post-op 2 months post-op 2 weeks post-op 2 years post-op 3 months post-op 3 weeks post-op 4 months post-op 5 months post-op 6 months post-op 6 weeks post-op 9 months post-op. Sort by:. Most visite...
http://realself.com/neck-lift/answers/hernia
*  Errata-Therapeutic Choices - CPhA
... Errata-Therapeutic Choices. Errata-Therapeutic Choices. Errata-Therapeutic Choices for Minor Ailments. Errata-Therapeutic Choices Errors and their corrections for CPhA's Compendium of Therapeutic Choices. Please print and insert into your copy of Compendium of Therapeutic Choices, 7th edition. Please print and insert into your copy of Compendium of Therapeutic Choices, 7th edition. Please print and insert into your copy of Compendium of Therapeutic Choices, 7th edition. Please print and insert into your copy of Compendium of Therapeutic Choices, 7th edition. Please print and insert into your copy of Compendium of Therapeutic Choices, 7th edition. Correction in Chapter 35, Hypertension, Table 6, p. 472 For trandolapril/verapamil, the paragraph on inotropic effects in the Drug Interactions column should read: Additive negative inotropic effects with amiodarone, beta-blockers, digoxin. A corrected version is provided below. Please print and insert into your copy of Therapeutic Choices, 6th edition. Correcti...
http://pharmacists.ca/index.cfm/education-practice-resources/canadian-drug-therapeutic-information/errata/errata-tc/
*  Brazilian Butt Lift DD Cup Doctor Answers, Q&A, Tips - RealSelf
... Warning: You do not have JavaScript enabled. Parts of this website will not display or function properly. For a better experience, please enable JavaScript. For Doctors Join Sign in. . Treatments. Video. Find a Doctor. Ask a Doctor. Write a Review. For Doctors. Sign In. Join. Search. Treatments. Brazilian Butt Lift. Q A. Brazilian Butt Lift Q A. Ask a doctor. Reviews 11202. Pictures 2535. Videos 208. Q A 8052. Forum 1916. Guides. Cost. DD Cup + Brazilian Butt Lift. Narrow 7 questions by:. All - Before or After Before After. All - Weight 090-109 lbs 110-129 lbs 130-149 lbs 150-169 lbs 170-189 lbs 190-209 lbs 210-229 lbs 230-249 lbs 250-269 lbs 270-289 lbs 290-309 lbs weight fluctuation. All - Ethnicity African American Afro-Caribbean Asian Caucasian Latina hispanic multi-racial. All - Post-Op 1 day post-op 1 month post-op 1 week post-op 1 year post-op 10 days post-op 2 days post-op 2 months post-op 2 weeks post-op 2 years post-op 3 days post-op 3 months post-op 3 weeks post-op 4 days post-op 4 months post...
http://realself.com/brazilian-butt-lift/answers/dd-cup
*  .. About Us .. Borg4x4 – Bucks and Oxon 4×4 Response Group.
About Us Borg4x4 – Bucks and Oxon 4×4 Response Group. We’re an unusual combination of a local response group and a regular 4×4 club. This means that when weather or other situation means that the local authorities need our help, we are on hand with vehicles, training and experience to provide help where its needed, and when not involved in that, we get together for 4×4-related events of all varieties. Emergency response As many of you will be aware the club’s name is derived from the volunteer stand-by service that we operate at the behest of Bucks County Council’s Emergency Planning team. The Emergency Planning Team based at County Hall in Aylesbury are responsible for co-ordinating the County’s response to civil emergencies anywhere in Bucks. Obviously in the case of a major incident involving a serious threat to life, the response will be in tandem with the front-line emergency services. However for a number of years the County has maintained and supported several volunteer groups whose services coul...
http://borg4x4.org/?option=com_jcalpro&Itemid=61&extmode=day
*  Ultherapy Damage Doctor Answers, Q&A, Tips - RealSelf
... Parts of this website will not display or function properly. For Doctors Join Sign in. Treatments. Find a Doctor. Ask a Doctor. For Doctors. Treatments. Ultherapy. Ultherapy Q A. Ask a doctor. Damage + Ultherapy. All - Condition double chin droopy fat lines loose skin nerve damage numb pain ptosis puffiness sagging side effects swelling swollen wrinkles. All - Post-Op 1 day post-op 1 month post-op 1 week post-op 1 year post-op 2 days post-op 2 months post-op 2 weeks post-op 3 days post-op 3 months post-op 3 weeks post-op 4 days post-op 4 months post-op 6 months post-op 6 weeks post-op 7 months post-op. What is Damaged by Ulthera During the Treatment Process. What is it that is damaged under the skin during the Ulthera treatment process. READ MORE. I had Ultherapy done 9 months ago. READ MORE. I had Ultherapy done 8 months ago and I had nerve trauma. The right side of my lip is noticeably droopingI Aso have other damage but the lip on one side seems to have the most.I was told by a doctor that is... READ ...
http://realself.com/ultherapy/answers/damage
*  S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer - F
Patients must have measurable disease; all measurable lesions must be assessed by physical examination, CT or MRI scan or plain X-ray within 28 days prior to registration; tests to assess non-measurable disease must be performed within 42 days prior to registration Patients with symptomatic, unstable or untreated brain metastases are not eligible; previous treatment must have been completed at least 28 days prior to registration Patients must have a Zubrod performance status of 0-2 Patients must not have received radiotherapy, chemotherapy, biologic therapy or any other investigational drug for any reason within 28 days prior to registration; all toxicities from prior treatment must have been resolved in the opinion of the treating investigator ; patients whose only disease is within a previous radiation therapy port must demonstrate clearly progressive disease prior to registration; patients must have resolution of all toxicities from any prior therapy to = grade 1 CTCAE version 3.0 ; patients must not have ...
https://clinicaltrials.gov/ct2/show/study/NCT00068783?show_locs=Y
*  Labiaplasty Repair Doctor Answers, Q&A, Tips - RealSelf
... Warning: You do not have JavaScript enabled. Parts of this website will not display or function properly. For a better experience, please enable JavaScript. For Doctors Join Sign in. Treatments. Find a Doctor. Ask a Doctor. Write a Review. For Doctors. Sign In. Join. Search. Treatments. Labiaplasty. Labiaplasty Q A. Ask a doctor. Reviews 436. Pictures 914. Videos 89. Forum 52. Guides. Cost. Repair + Labiaplasty. Narrow 3 questions by:. All - Condition extra skin hanging hurt infection irritation itching itchy nausea numb pain protruding sensitivity swelling swollen uneven. All - Age age 17 or under age 18-24 age 25-34 age 35-44 age 45-54. All - Post-Op 1 day post-op 1 month post-op 1 week post-op 1 year post-op 10 days post-op 10 months post-op 2 days post-op 2 months post-op 2 weeks post-op 3 weeks post-op 4 days post-op 4 months post-op 5 months post-op 6 months post-op. Sort by:. Most visited. Recent. Answers. . Labia Repair After Giving Birth. I gave birth 7 mos ago had 2nd degree laceration was sutu...
http://realself.com/labiaplasty/answers/repair
*  Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors - Full Te
Verified September 2015 by Children's Oncology Group Sponsor: Children's Oncology Group Collaborator: National Cancer Institute NCI Information provided by Responsible Party : Children's Oncology Group. Further study details as provided by Children's Oncology Group:. To identify key adverse events developing in patients cases with a primary cancer diagnosed at age 21 or younger. Jude Children's Research Hospital as per the requirements; please note: if a patient is currently receiving active cancer treatment, it is preferable to obtain the blood sample at a time when the patient's white blood cell WBC is 2,000 Written informed consent from the patient and/or the patient's legally authorized guardian In active follow up by a COG institution; active follow up will be defined as date of last visit or contact by a COG institution within the past 24 months; any type of contact, including contact specifically for participation in ALTE03N1, qualifies as active follow-up; please note: treatment on a COG or legacy gro...
https://clinicaltrials.gov/ct2/show/NCT00082745?term=Stroke&lup_s=06/08/2013&lup_d=14&show_rss=Y&sel_rss=mod14
*  www.biomedcentral.com - Table
... Table 1. Phase II trials of sorafenib in DTC. Trial. Efficacy Results. Grade ≥ 3 AEs in ≥ 5%. of Patients. Other. Single-arm trial. N = 55 total;. n = 47 DTC. mPFS = 84 weeks*. SD = 53.3% †. PR = 23.3% †. DCR = 76.6% †. OS = 140 weeks †. Hypertension 13%, hand-foot syndrome 10%, rash 10%, weight loss 10%, diarrhea 7%, elevated LFTs 7% ‡. • Dose reduction due to AEs was required in 47% of patients initial analysis. • Median duration of treatment at initial analysis 30 of 55 patients accrued = 27 weeks. • BRAF genotyping n = 16 : mPFS = 84+ weeks in DTC patients with BRAF V600E, compared with 54 weeks in those with BRAF wt P = 0.028. Single-arm component chemotherapy-naive patients with DTC of two-arm trial N = 56 total; n = 41 DTC. mPFS = 65 weeks*. SD = 57%*. PR = 15%*. DCR = 72%*. Fatigue, HSFR 11% each ; weight loss, skin rash, hypertension, diarrhea, stomatitis, tongue/tooth pain, abdominal/rectal pain, proximal myopathy, back pain, general pain, hand/foot pain, arthralgia, colon perforation 5% each. ...
http://biomedcentral.com/1471-2407/11/349/table/T1
*  Clinical Trial COGALTE03N1 - Vanderbilt-Ingram Cancer Center
Jude Children's Research Hospital as per the requirements; please note: if a patient is currently receiving active cancer treatment, it is preferable to obtain the blood sample at a time when the patient's white blood cell WBC is 2,000 Written informed consent from the patient and/or the patient's legally authorized guardian In active follow up by a COG institution; active follow up will be defined as date of last visit or contact by a COG institution within the past 24 months; any type of contact, including contact specifically for participation in ALTE03N1, qualifies as active follow-up; please note: treatment on a COG or legacy group therapeutic protocol for the primary cancer is NOT required ELIGIBILITY CRITERIA CONTROLS CONTROL: Diagnosis of primary cancer at age 21 or younger, irrespective of current age CONTROLS: No prior history of allogeneic non-autologous hematopoietic cell transplant CONTROLS: No clinical evidence of any of the following key adverse events: Cardiac dysfunction CD ; please note: if ...
http://vicc.org/ct/protocol-results.php?protocol-no=COGALTE03N1
*  Labiaplasty Advantage Doctor Answers, Q&A, Tips - RealSelf
... Warning: You do not have JavaScript enabled. Parts of this website will not display or function properly. For a better experience, please enable JavaScript. For Doctors Join Sign in. . Treatments. Video. Find a Doctor. Ask a Doctor. Write a Review. For Doctors. Sign In. Join. Search. Treatments. Labiaplasty. Q A. Labiaplasty Q A. Ask a doctor. Reviews 437. Pictures 914. Videos 89. Q A 1231. Forum 52. Guides. Cost. Advantage + Labiaplasty. Narrow 1 question by:. All - Before or After Before After. All - Condition extra skin hanging hurt infection irritation itching itchy nausea numb pain protruding sensitivity swelling swollen uneven. All - Age age 17 or under age 18-24 age 25-34 age 35-44 age 45-54. All - Post-Op 1 day post-op 1 month post-op 1 week post-op 1 year post-op 10 days post-op 10 months post-op 2 days post-op 2 months post-op 2 weeks post-op 3 weeks post-op 4 days post-op 4 months post-op 5 months post-op 6 months post-op. Sort by:. Most visited. Recent. Answers. . Benefits of Massage After La...
http://realself.com/labiaplasty/answers/advantage
*  Surgical Follow-up and Outcomes sub-cluster 10
Clinicopathological characteristics and long-term outcomes of colorectal cancer in elderly Chinese patients ... PURPOSE: The aim of this study was to determine the clinicopathological characteristics and outcomes of Chinese colorectal cancer CRC patients aged 75 years and older undergoing potentially curative surgery. METHODS: A total of 2,482 CRC patients at TNM stage I-III undergoing surgical treatment between 1995 and 2005 were evaluated, and patients ... Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in ... The aim of this study was to evaluate indications for emergency surgery in patients 80 years of age with PD. Mortality and complications in elderly patients undergoing cardiac surgery. PURPOSE: The purpose of the study was to analyze postoperative complications, mortality, and related factors of elderly patients undergoing cardiac surgery. Clinical-surgical data, postoperative complications, and mortality were ... The aim of this study is to assess the...
http://biomedsearch.com/cluster/27/Surgical-Follow-up-and-Outcomes/sub-10-p6.html
*  Thermage 5 Months Post-op Doctor Answers, Q&A, Tips - RealSelf
... Warning: You do not have JavaScript enabled. Parts of this website will not display or function properly. For a better experience, please enable JavaScript. For Doctors Join Sign in. . Treatments. Video. Find a Doctor. Ask a Doctor. Write a Review. For Doctors. Sign In. Join. Search. Treatments. Thermage. Q A. Thermage Q A. Ask a doctor. Reviews 345. Pictures 88. Videos 11. Q A 410. Forum 19. Guides. Cost. 5 Months Post-op + Thermage. Narrow 2 questions by:. All - Before or After Before After. All - Condition cellulite crepey skin droopy eye bags fine lines hooding laxity loose loose skin pain sagging side effects stretch marks turkey neck wrinkles. All - Post-Op 3 days post-op 4 months post-op 6 months post-op. All - Gender female male. Sort by:. Most visited. Recent. Answers. . 5 mths post Thermage to face, I have side effects that include, swelling,creeping sensation in eyes and gaunt, wrinkly skin. I had thermage procedure on whole face 12/20/13. I was told not bad side effects at all??. Since then, ...
http://realself.com/thermage/answers/5-months-post-op
*  An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combin
... ations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy - Full Text View - ClinicalTrials.gov. Skip to Main Content. A service of the U.S. National Institutes of Health Example: "Heart attack" AND "Los Angeles" Search for studies:. Advanced Search. Help. Studies by Topic. Glossary. Find Studies. Basic Search. Advanced Search. See Studies by Topic. See Studies on Map. How to Search. How to Use Search Results. How to Find Results of Studies. How to Read a Study Record. About Clinical Studies. Learn About Clinical Studies. Other Sites About Clinical Studies. Glossary of Common Site Terms. Submit Studies. Why Should I Register and Submit Results. FDAAA 801 Requirements. How to Apply for an Account. How to Register Your Study. How to Edit Your Study Record. How to Submit Your Results. Frequently Asked Questions. Support Materials. Training Materials. Resources. Selected Publications. Clinical Alerts and Advisories. RSS Feeds. Trends, ...
https://clinicaltrials.gov/ct2/show/NCT01103960
*  Response Evaluation Criteria in Solid Tumors
... 'Response Evaluation Criteria In Solid Tumors' 'RECIST' is a set of published rules that define when tumors in cancer patients improve "respond", stay the same "stabilize", or worsen "progress" during treatment. The criteria were published in February 2000 by an international collaboration including the European Organisation for Research and Treatment of Cancer EORTC, National Cancer Institute of the United States, and the National Cancer Institute of Canada Clinical Trials Group. Today, the majority of clinical trials evaluating cancer treatments for objective response in solid tumors use RECIST. These criteria were developed and published in February 2000, and subsequently updated in 2009. They are specifically NOT meant to determine whether patients have improved or not, as these are tumor-centric, not patient centric criteria. This distinction must be made by both the treating physicians and the cancer patients themselves. It is not intended that these RECIST guidelines play a role in that decision m...
https://en.wikipedia.org/wiki/Response_Evaluation_Criteria_in_Solid_Tumors
*  A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Neph
... ropathy - Tabular View - ClinicalTrials.gov. A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy This study has been terminated. Sponsor: Pfizer Information provided by Responsible Party : Pfizer. Study Results. Current Primary Outcome Measures ICMJE submitted: September 24, 2013. Change From Baseline in Serum Potassium at Day 8 Baseline value calculated as the average of -24 hours pre-dose measurement on Day -1 and 0 hours immediately pre-dose measurement on Day 1. Day 8 value calculated was average of 0 hours immediately pre-dose measurements on Day 7 and 8. Change From Baseline in Serum Potassium at Day 15 Baseline value calculated as the average of -24 hours pre-dose measurement on Day -1 and 0 hours immediately pre-dose measurement on Day 1. Day 15 value calculated was average of 0 hours immediately pre-dose measurement on Day 14 and measurement obtained prior to discharge on Day 15. Original Primary Outcome Measures ICMJE submitted: December 6,...
https://clinicaltrials.gov/ct2/show/record/NCT01488877?view=results
*  A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Partici
Secondary Outcome Measures: Time to first composite CV endpoint of confirmed CV-related death, nonfatal MI, and nonfatal stroke Stage 1 Time to first event for each of the individual CV endpoints: confirmed CV-related death, MI fatal + nonfatal, stroke fatal + nonfatal, and unstable angina requiring hospitalization Stage 1 Time to all-cause mortality Stage 1 Change from baseline in A1C at Week 156 Change from baseline in fasting plasma glucose FPG at 4 months Percentage of participants achieving a target A1C 7.0 % 53 mmol/mol at 4 months Time to initiation of long-term insulin therapy long-term insulin therapy is defined as a continuous period of insulin use of more than 3 months in participants not receiving insulin at baseline Change from baseline in FPG at Week 18 in a sub-study of participants taking insulin with or without metformin Period 1 Percentage of participants achieving a target A1C 7.0 % 53 mmol/mol at Week 18 in a sub-study of participants taking insulin with or without metformin Period 1 Perce...
https://clinicaltrials.gov/ct2/show/study/NCT01703208?term=heart attack&lup_s=10/25/2013&lup_d=14&show_rss=Y&sel_rss=mod14&show_locs=Y
*  prilosec long term effects - MedHelp
... Full Site. Heart Heart Disease. Prilosec long term effects. Read More. Read More. Read More. Read More. Read More. You should get good information on potential side effects and how long it takes to begin to have full effect. Read More. Prilosec, Nexium Side Effects : Acid Reflux Medication Heart Attack Class Action Lawsuit Investigation A recent study found that proton pump inhibitor heartburn treatments such as Nexium, Prilosec and Prevacid may be linked to an increased risk of heart attack, heart failure or sudden cardiac death. Read More. Read More. Read More. She assured me that there were no studies that showed any side effects from the long term use of PPI's. Read More. so, therefore anyone with long term side effects ... Read More. severe major clinical depression, severe anxiety, severe constant fungal infections, homocysteine in imminent heart attack range, severe angina pain, severe stomach pain nexium worsened her gastritis, sky high blood pressure - given less than 5 years to live by an inter...
http://healthquestions.medhelp.org/prilosec-long-term-effects
*  Leupold VX I vs VX II vs VX III
... New Posts. Firearm Discussions Forum. Optics, Mounts, and Sights. Leupold VX I vs VX II vs VX III. Welcome to GunSite. Thread: Leupold VX I vs VX II vs VX III. View Profile. View Forum Posts. Private Message. Join Date Dec 2008 Location Dubben Age 44 Posts 946. Leupold VX I vs VX II vs VX III. Reply With Quote. View Profile. View Forum Posts. Private Message. Join Date Feb 2009 Age 38 Posts 845. Re: Leupold VX I vs VX II vs VX III All Leupold scopes are impact tested to the same level. Reply With Quote. View Profile. View Forum Posts. Private Message. Join Date May 2010 Location Pretoria Age 35 Posts 782. Re: Leupold VX I vs VX II vs VX III According to Leupold the VxIII's lenses are also more scratch resistant thanks to Diamondcoat. Reply With Quote. View Profile. View Forum Posts. Private Message. Join Date Dec 2008 Location Dubben Age 44 Posts 946. Join Date Oct 2010 Location Southern California, USA Posts 864. Re: Leupold VX I vs VX II vs VX III I have an older 3-9 VX-2 on my 340 weatherby. Re: Leupo...
http://gunsite.co.za/forums/showthread.php?11824-Leupold-VX-I-vs-VX-II-vs-VX-III
*  Patente US6261242 - Biopsy sampler - Google Patentes
... . . . . Patentes. The invention features an assembly for taking a biopsy sample from a site within the body of a patient. The assembly includes a resecting device having a cutter near its distal end for resecting and containing a tissue sample and a sheath exterior to the resecting device and sized to be present within... . . . . . Fecha de prioridad 31 Mar 1995. Tarifa Pagadas. . DE69632906D1,. DE69632906T2,. EP0818975A1,. EP0818975A4,. EP0818975B1,. US5928163,. WO1996029945A1. . Inventores Troy W. Roberts,. Bruce H. Diamond. Cesionario original Boston Scientific Corporation. Exportar cita BiBTeX,. EndNote,. RefMan. Citas de patentes 11,. Citada por 75,. Clasificaciones 30,. Eventos legales 7. Enlaces externos:. USPTO,. . Espacenet. Biopsy sampler US 6261242 B1 Resumen The invention features an assembly for taking a biopsy sample from a site within the body of a patient. The assembly includes a resecting device having a cutter near its distal end for resecting and containing a tissue sample and a sheath...
http://google.es/patents/US6261242?dq=flatulence
*  Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment - Full Text View
... - ClinicalTrials.gov. National Institutes of Health Example: "Heart attack" AND "Los Angeles" Search for studies:. Find Studies. How to Find Results of Studies. About Clinical Studies. Learn About Clinical Studies. Submit Studies. ClinicalTrials.gov Background. Find Studies Study Record Detail. Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment This study has been completed. Sponsor: Oshadi Drug Administration Information provided by Responsible Party : Oshadi Drug Administration. ClinicalTrials.gov Identifier: NCT01201018 First received: September 12, 2010 Last updated: June 20, 2012 Last verified: June 2012 History of Changes. The study will be non randomized, open label, dose rising study in cancer patients. Cancer treatment is consisting of 2 different drugs: Oshadi D and Oshadi R that will be administered orally. The study will include two sessions: A single dose period to evaluate acute toxicity of each drug Consecutive multiple increment dose escalation period of b...
https://clinicaltrials.gov/ct2/show/NCT01201018
*  GSK Clinical Study Register - Study LEX106430
... . Search text Submit search. Home. Find Studies. Browse Medical Conditions Browse Compound Names Advanced Search. Patient Level Data. Products. Metrics. Contact GSK. Quick Search. Medical Condition. A-F G-K L-P Q-U V-Z. Compound Name. A-F G-K L-P Q-U V-Z 0-9. Useful Links Paroxetine Information. Patient Level Data Request System. ClinicalTrials.gov. clinicaltrialsregister.eu. European Public Assessment Reports. FDA Approved Drug Products. FDA Postmarket Drug Safety Information for Patients and Providers. For more information on this register please call +1 877-379-3718. GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. ClinicalTrial.gov is a database that provides summary protocol information ...
http://gsk-clinicalstudyregister.com/study/LEX106430
*  NewYork-Presbyterian/Queens - Cancer Treatment: Surgery For Cancer Treatment
... Surgery. Cancer Center Cancer Treatment: Surgery For Cancer Treatment How is surgery used in cancer treatment. It provides the best chance to stop many types of cancer, and it also plays a part in diagnosing, staging, and supporting cancer treatment. Having surgery for cancer is different for every patient, depending on the type of surgery, the type of cancer, and the patient's health. Surgeons use curative surgery when the cancerous tumor is localized to a specific area of the body. However, other types of cancer treatments, such as radiation, may be used before or after the surgery. Preventive surgery is used to remove tissue that does not contain cancerous cells, but may develop into a malignant tumor. Other types of cancer treatment, such as chemotherapy and radiation, may be used after debulking surgery is performed. What are the risks and potential side effects of surgery for cancer treatment. This is one of the reasons why learning about your cancer and cancer treatment is important. Cryosurgery i...
http://nyhq.org/diw/Content.asp?PageID=DIW007356&language=Korean
*  Resources for Families of Addicted Individuals - Treatment Solutions
... Menu Addiction Info Drug Abuse Information Intervention. Addiction Recovery. Drug Abuse Information. Drug Detox. Heroin Detox. Alcohol Detox. Rehab Drug Rehab. Substance Abuse Rehab. Alcohol Rehab. Addiction Drug Abuse. Insurance Info Addiction Treatment and Insurance Aetna Covered Drug Rehab. Anthem Covered Drug Rehab. Tricare Covered Drug Rehab. Asuris Covered Drug Rehab. Health Net Covered Drug Rehab. Humana Covered Drug Rehab. Kaiser Covered Drug Rehab. About Us About Us Mission, Values, Vision. Contact & Feedback FAQs. Contact Us. Resources Information Resources FREE CEU Courses. FAQs. Get Help For Yourself or Family Member. Resources for Families of Addicted Individuals Post 683 of 728. Help is out there, and below are some resources designed to treat the family members of addicts. Nar-Anon helps families of individuals addicted to narcotics, and it also holds free meetings throughout the country. Co-Dependents Anonymous is another support group for spouses. Parents of Addicts. Adolescents addicted...
http://treatmentsolutions.com/resources-for-families-of-addicted-individuals/
*  5Dc a good option?
5Dc a good option. 5Dc a good option. jdramirez Canon EF 300mm f/2.8L IS II. Re: 5Dc a good option. Reply #15 on: March 24, 2013, 10:58:18 PM. Re: 5Dc a good option. Reply #15 on: March 24, 2013, 10:58:18 PM. Re: 5Dc a good option. Reply #16 on: March 24, 2013, 11:00:17 PM. Quote from: jdramirez on March 24, 2013, 10:58:18 PM. But as someone else said, the lenses that work with full frame, especially the good ones are not cheap. jdramirez Canon EF 300mm f/2.8L IS II. Re: 5Dc a good option. Reply #17 on: March 24, 2013, 11:02:43 PM. Re: 5Dc a good option. Reply #18 on: March 24, 2013, 11:31:47 PM. Re: 5Dc a good option. Reply #19 on: March 24, 2013, 11:36:04 PM. If I was to buy a 5Dc I may have enough money next year to buy a 5D3 and keep the 5Dc as a backup, also the 5Dc is the cheapest way to get into/practice with full frame. So I guess from what I have been reading I have to options, they are: • Buy a used 5Dc for around £400 and buy an 85mm 1.8 Which I think will fit in well because my two L lenses are f/...
http://canonrumors.com/forum/index.php?topic=13769.msg251854
*  Washing mitt
... thumb a washing mitt a washing mitt is a piece of terry cloth shaped like a pouch that the hand fits in it is being used as an aid in washing the body for example to apply soap to the body and to remove the soap with a rinsed out washing mitt it can also be used to freshen up the face usually a towel is used to dry off the body afterwards a washing mitt is especially useful for people that like to wash themselves at a sink and do not wish to spill or waste much water the washing mitt is also a good tool for nurses and caregivers who wash their patients in their beds an expansion on the washing mitt is the showercloth with which also the back can be washed there are also special sponges which can be used in the shower or in the bathtub in combination with a shower gel in the case of bruises or injuries a washing mitt can be filled with ice so that it can be used as an ice bag it is often being said that the washing mitt is a typical dutch product however washing mitts are also being used in germany france...
https://en.wikipedia.org/wiki/Washing_mitt
*  Glossary -- 1 (1): 32 -- Evidence-Based Nursing
Online First. Current issue. About the journal. Subscribe. Online First. Current issue. Absolute risk reduction ARR : the arithmetic difference in outcome rates between control and experimental patients in a trial; usually reported as a percentage %. Control event rate CER : rate % of outcome of interest observed in the control group. Crossover trial : a method of comparing 2 interventions in which patients are switched to the alternative intervention after a specified period of time. Experimental event rate EER : rate % of outcome of interest observed in the experimental group. Intention to treat analysis ITT : all patients are analysed in the groups to which they were randomised, regardless of failure to complete the intervention or receiving the wrong intervention. Odds ratio OR : describes the odds of a patient in the experimental group having an event divided by the odds of a patient in the control group having the event or the odds that a patient was exposed to a given risk factor divided by the odds th...
http://ebn.bmj.com/content/1/1/32.2.full
*  GSK Clinical Study Register - Study 107863
... . Search text Submit search. Home. Find Studies. Browse Medical Conditions Browse Compound Names Advanced Search. Patient Level Data. Products. Metrics. Contact GSK. Quick Search. Medical Condition. A-F G-K L-P Q-U V-Z. Compound Name. A-F G-K L-P Q-U V-Z 0-9. Useful Links Paroxetine Information. Patient Level Data Request System. ClinicalTrials.gov. clinicaltrialsregister.eu. European Public Assessment Reports. FDA Approved Drug Products. FDA Postmarket Drug Safety Information for Patients and Providers. For more information on this register please call +1 877-379-3718. GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. ClinicalTrial.gov is a database that provides summary protocol information ...
http://gsk-clinicalstudyregister.com/study/107863
*  GSK Clinical Study Register - Study 101468/196
... . Search text Submit search. Home. Find Studies. Browse Medical Conditions Browse Compound Names Advanced Search. Patient Level Data. Products. Metrics. Contact GSK. Quick Search. Medical Condition. A-F G-K L-P Q-U V-Z. Compound Name. A-F G-K L-P Q-U V-Z 0-9. Useful Links Paroxetine Information. Patient Level Data Request System. ClinicalTrials.gov. clinicaltrialsregister.eu. European Public Assessment Reports. FDA Approved Drug Products. FDA Postmarket Drug Safety Information for Patients and Providers. For more information on this register please call +1 877-379-3718. GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. ClinicalTrial.gov is a database that provides summary protocol information ...
http://gsk-clinicalstudyregister.com/study/101468/196
*  GSK Clinical Study Register - Study 109801
... . Search text Submit search. Home. Find Studies. Browse Medical Conditions Browse Compound Names Advanced Search. Patient Level Data. Products. Metrics. Contact GSK. Quick Search. Medical Condition. A-F G-K L-P Q-U V-Z. Compound Name. A-F G-K L-P Q-U V-Z 0-9. Useful Links Paroxetine Information. Patient Level Data Request System. ClinicalTrials.gov. clinicaltrialsregister.eu. European Public Assessment Reports. FDA Approved Drug Products. FDA Postmarket Drug Safety Information for Patients and Providers. For more information on this register please call +1 877-379-3718. GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. ClinicalTrial.gov is a database that provides summary protocol information ...
http://gsk-clinicalstudyregister.com/study/109801
*  Rough patch right now, still on pristiq and a bit more
... Posts: 362 Rec's: 2 Gender:. Rough patch right now, still on pristiq and a bit more on: June 10, 2014, 07:31:10 PM. Tweet Logged. insights Hero Member. Posts: 5585 Country:. Rec's: 116 Gender: Mood: Curious. Re: Rough patch right now, still on pristiq and a bit more Reply #1 on: June 10, 2014, 09:24:32 PM. Quote from: 2sungo on June 10, 2014, 07:31:10 PM. Posts: 362 Rec's: 2 Gender:. Re: Rough patch right now, still on pristiq and a bit more Reply #2 on: June 11, 2014, 09:47:17 PM. Ian, I did try to up Pristiq to 100 once but it made me more anxious and my pulse and bp went up how much was med and how much was anxiety I don t know so I don t want to go that route again. The good news is that today was better than yesterday, the remeron does let me sleep well, but when I got up the pulse was already up in the high 90s which for me means the anxiety is likely to be significant. Tweet Logged. Posts: 362 Rec's: 2 Gender:. Re: Rough patch right now, still on pristiq and a bit more Reply #3 on: June 15, 2014, ...
http://anxietyzone.com/index.php/topic,89519.msg499859.html
*  Rough patch right now, still on pristiq and a bit more
... Posts: 362 Rec's: 2 Gender:. Rough patch right now, still on pristiq and a bit more on: June 10, 2014, 07:31:10 PM. Tweet Logged. insights Hero Member. Posts: 5585 Country:. Rec's: 116 Gender: Mood: Curious. Re: Rough patch right now, still on pristiq and a bit more Reply #1 on: June 10, 2014, 09:24:32 PM. Quote from: 2sungo on June 10, 2014, 07:31:10 PM. Posts: 362 Rec's: 2 Gender:. Re: Rough patch right now, still on pristiq and a bit more Reply #2 on: June 11, 2014, 09:47:17 PM. Ian, I did try to up Pristiq to 100 once but it made me more anxious and my pulse and bp went up how much was med and how much was anxiety I don t know so I don t want to go that route again. The good news is that today was better than yesterday, the remeron does let me sleep well, but when I got up the pulse was already up in the high 90s which for me means the anxiety is likely to be significant. Tweet Logged. Posts: 362 Rec's: 2 Gender:. Re: Rough patch right now, still on pristiq and a bit more Reply #3 on: June 15, 2014, ...
http://anxietyzone.com/index.php/topic,89519.msg500856.html
*  Three Times Daily Dosing of UT-15C - Full Text View - ClinicalTrials.gov
... National Institutes of Health Example: "Heart attack" AND "Los Angeles" Search for studies:. Find Studies. How to Find Results of Studies. How to Read a Study Record. About Clinical Studies. Learn About Clinical Studies. Other Sites About Clinical Studies. How to Edit Your Study Record. ClinicalTrials.gov Background. Find Studies Study Record Detail. Three Times Daily Dosing of UT-15C This study has been completed. Sponsor: United Therapeutics Information provided by Responsible Party : United Therapeutics. ClinicalTrials.gov Identifier: NCT01746485 First received: August 16, 2012 Last updated: December 10, 2012 Last verified: December 2012 History of Changes. How to Read a Study Record. To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers. Healthy. Drug: UT-15C. Official Title: A PK Evaluation of Three Times Daily Dosing of UT-15C SR Tablets in Healthy Subjects. Drug Information available for: Treprostinil Treprostinil diolamine U.S. Further study details as provi...
https://clinicaltrials.gov/ct2/show/NCT01746485
*  .. Avastin Label Changes Reignites Debate: Is OS or PFS the Better Regulatory End
FDA s success in removing Avastin s metastatic breast cancer MBC indication has sparked a longstanding debate in drug development circles: What is the best proof that a drug works and should be approved. A panel discussion held November 29 in Cambridge, MA, debated whether the primary endpoint for regulatory sanction should remain overall survival OS or if it should change to progression-free survival PFS. CDER pointed to new studies, one of which showed a difference in overall survival for patients with MBC of less than two months from 24.8 months to 26.5 months. FDA countered that the primary endpoint should instead be overall survival, while PFS should continue as a surrogate endpoint of clinical benefit. During the discussion held on November 29, called Surrogates or Survival: A Discussion on Endpoints in Multiple Myeloma Clinical Trials, moderator Anne Quinn Young recalled how cancer treatment has changed over the past 10 years. Both PFS and OS are appropriate endpoints to define clinical benefits for pa...
http://genengnews.com/keywordsandtools/print/3/25316/
*  Community Health Obesity and Diabetes Related Indicators: 2008 - 2012 | State of New York | Open Dat
Sort Sort field 1 column No Sort County Name County Code Region Name Indicator Number Indicator Total Event Counts Denominator Denominator Note Measure Unit Percentage/Rate 95% CI Data Comments Data Years Data Sources Quartile Mapping Distribution ; sort field 1 direction Ascending Descending. Sort field 5 column No Sort County Name County Code Region Name Indicator Number Indicator Total Event Counts Denominator Denominator Note Measure Unit Percentage/Rate 95% CI Data Comments Data Years Data Sources Quartile Mapping Distribution ; sort field 5 direction Ascending Descending. Sort field 6 column No Sort County Name County Code Region Name Indicator Number Indicator Total Event Counts Denominator Denominator Note Measure Unit Percentage/Rate 95% CI Data Comments Data Years Data Sources Quartile Mapping Distribution ; sort field 6 direction Ascending Descending. Sort field 7 column No Sort County Name County Code Region Name Indicator Number Indicator Total Event Counts Denominator Denominator Note Measure Un...
https://health.data.ny.gov/Health/Community-Health-Obesity-and-Diabetes-Related-Indi/tchg-ruva/alt?page=7
*  Comment tel SNF 2010-07-29 13:39:18: Restarted after power out
comment tel snf restarted after power out comment tel snf restarted after power out tberg at snf stanford edu tberg at snf stanford edu mon aug pdt previous message problem tel snf no process gases next message shutdown tel snf power fail messages sorted by noted previous message problem tel snf no process gases next message shutdown tel snf power fail messages sorted by more information about the tel pcs mailing list...
http://snf.stanford.edu/pipermail/tel-pcs/2010-August/000225.html
*  WeeChat dev news
multiple layouts support see this post nick prefix/suffix are now dynamic and managed by core instead of irc plugin see this post unmask irc join if nick speaks some minutes after the join see this post new option irc.look.display join message to disable some messages after joining a channel new option irc.look.pv buffer to automatically merge private buffers add support of UHNAMES add DH-AES encryption method for SASL multiple irc servers allowed on same port for irc protocol in relay plugin add WebSocket server support RFC 6455 in relay plugin for irc and weechat protocols see this post send nicklist diff in relay plugin weechat protocol add control of autoload for scripts optimizations in aspell plugin New options:. add option "diff" for command /set, display default values in output of /set add color support in prefix options add command /eval, use expression in conditions for bars connect by default with IPv6 to servers with fallback to IPv4 add aspell suggestions add support of tags in irc messages and ...
http://dev.weechat.org/
*  IBC Support: FAQ
... Home About IBC Newly Diagnosed. Books Caregivers Mailing List Essays Patient Stories Treatment Info Questions/FAQ Resources Feedback Donations IBC Foundation Remembering Cynthia. Treatment Options chemo only, not HDC/SCR : CAF protocols Taxotere Herceptin What is the best order of treatment, i.e.. chemo, rads, MRM, HDC/SCR or MRM, chemo, rads, chemo. Radiation the next most addressed topic Radiation burns and skin care Prevention of skin breakdown Radiation combined with other therapies. HDC/SCR What to expect/Where should I go. Post treatment experiences Where to do HDC in treatment plan i.e.. before, MRM, after rads, etc. Should I do it?Who else has done it. Does it work. Chemo all types and:. fatigue side effects MRM Neuropathy and Taxotere. Skin Mets what is it/What does it look like Treatment Recurrences How to tell the difference between mets and other skin problems. Tamoxifen and Side effects Depression Blood clots Hot flashes Femera. Personal care. Where to get wigs, bras, breast forms Hair, nail...
http://ibcsupport.org/newfaq.html
*  www.arthritis-research.com - Figure
... Resolution: standard / high Figure 1. Study flow. Responders were defined as patients who received a minimum dosage of milnacipran 100 mg/day and achieved ≥50% pain improvement after long-term treatment. a Patients not meeting responder criteria were analyzed separately, but the results for these patients are not presented in the current report. "Nonresponder" does not necessarily imply no improvement. b Worsening of fibromyalgia requiring alternative treatment, which was one of the loss of therapeutic response LTR criteria used for the primary efficacy analysis and for sensitivity analysis III. c Patients reaching the final study visit. d One patient who did not receive at least one dose of the study drug was excluded from safety and efficacy analyses. OL = open-label. Clauw et al. Arthritis Research Therapy 2013 15 :R88 doi:10.1186/ar4268 Download authors' original image....
http://arthritis-research.com/content/15/4/R88/figure/F1
*  SEER Training:Surgery
... Skip to Main Content. at the National Institutes of Health. www.cancer.gov. Search SEER Training:. SEER Training Modules. Print. Home. Glossary. Citation. Help. Home. Site-specific Modules. Breast Cancer. Treatment. Surgery. Cancer Registration Surveillance Modules. Site-specific Modules. Breast Cancer. Introduction. Types of Breast Cancer. Risk Factors. Signs & Symptoms. Five-Year Survival Rates. Review. Quiz. Anatomy. Quadrants of the Breast. Regional Lymph Nodes. Review. Abstracting, Coding, & Staging. ICD-O Site Codes. Morphology & Grade. Extent of Disease Evaluation. Physical Exam. Imaging. Tumor Markers. Endoscopies. Pathology. Staging. Abstracting Keys. Treatment. Surgery. Radiation Therapy. Chemotherapy. Hormonal Therapy. Immunotherapy. Systemic Therapy. Hands-on exercises unavailable; will return after updating. Resources. Archived Modules. Updates. Surgery. In the past, a positive biopsy was followed immediately by surgical treatment. This was called a one-step process. Currently, when a biopsy...
http://training.seer.cancer.gov/breast/treatment/surgery.html
*  Expert Speakers Forum: Dr. So: How do you determine appropriate treatment?
Expert Speakers Forum: Dr. So: How do you determine appropriate treatment. Questions. Glossary. 14. How do you determine which treatment should be used, and for how long. When I try to look at it objectively, the first thing you have to do is weigh the side effects - interferon has more side effects, and lamivudine and adefovir are very patient-friendly. There are three prognostic markers for treatment with interferon: viral load those with a lower load usually respond better, ALTs those with higher levels usually respond better, and duration of the infection those with shorter duration have a better response, usually. Most Asian patients do not meet these prognostic indicators for treatment with Interferon. Once again, I look at hepatitis from an infectious disease point of view - it is a chronic infection, and might need chronic suppression long-term just like HIV or diabetes. 13. Should the e-antigen be used to determine the success/end point of treatment. 15. Do you recommend treating patients with a high...
http://hepb.org/expforum/media-player.aspx?speakerID=drSo&topicID=determiningTreatment&language=English&mediaType=text&topicList=Questions
*  Kinein & Makaveli Fitness Thread - fitness & sports - Soompi Forums
1,238 posts in this topic Prev. Fan Level: Fanatic. 2,037 posts. Posted 22 Mar 2009. #4 Eating habits in the last week. #5 Your current exercise habits. * make sure you read the other posts as oftentimes you will pick up on certain themes or extra information that you didn't get in your own replies. Also the quality of the foods you eat is important ~ if you rely on carbs for more then 50% Cellulite response http://www.soompi.com/forums/index.php?sho... Quick links - Sample eating guidelines Posts #40 and 43 Carb information website Free Online Diet and Weight Loss Journal - Includes calorie information. To add onto Kinein's initial post, please post a GOAL, so we know how to help you. #4- I usually have 2-3 meals a day i cant eat from 8am to 2pm because of school, not too sure what to do about this. #6 YOUR GOAL 105lbs or 98lbs..but i think that would be too hard and too...skinny maybe. Ok doesn't even sound like you have much body fat or mass to work with anyway so don't worry about the slimming part lol. *...
http://forums.soompi.com/en/topic/200539-kinein-makaveli-fitness-thread/
*  The Baker Laboratory
... Skip to Main Content Area. news research Members Past Members publications employment contact info Links. Leaver-Fay A, O Meara MJ, Tyka M, Jacak R, Song Y, Kellogg EH, et al. Scientific benchmarks for guiding macromolecular energy function improvement. Meth Enzymol. 2013;523:109-43. Abstract. Tyka MD, Keedy DA, André I, DiMaio F, Song Y, Richardson DC, et al. Alternate States of Proteins Revealed by Detailed Energy Landscape Mapping. Journal of molecular biology. 2010. Abstract Download: tyka10A.pdf 2.13 MB....
http://bakerlab.org/biblio/author/396/
*  Step 2 - Locating Evidence
step locating evidence randomized controlled trials randomly assigns subjects into a treatment group or a control group in order to compare the efficacy of a particular treatment diagnosis etc against the current standard a placebo or no intervention at all...
http://atsu.edu/ebm/step2/evidence_pyramid/index_files/slide0030.htm
*  'No, I Ordered the Bunga Bunga Deluxe. And Make It Snappy, OK?'
'No, I Ordered the Bunga Bunga Deluxe. And Make It Snappy, OK?'....
http://gawker.com/5713281/no-i-ordered-the-bunga-bunga-deluxe-and-make-it-snappy-ok
*  The Disease & The Cure
the disease the cure the disease the cure redirect to know that you re alive...
https://en.wikipedia.org/wiki/The_Disease_&_The_Cure
*  The Disease and The Cure
... redirect to know that you re alive...
https://en.wikipedia.org/wiki/The_Disease_and_The_Cure
*  ..
Study Tips for Success and Growth in Nursing...
http://minoritynurse.com/
*  JAMA Network | JAMA Pediatrics | A Multisite Randomized Trial of the Effects of Physician Educati
A Multisite Randomized Trial of the Effects of Physician Education and Organizational Change in Chronic Asthma Care: Cost-effectiveness Analysis of the Pediatric Asthma Care Patient Outcomes Research Team II PAC-PORT II. A Multisite Randomized Trial of the Effects of Physician Education and Organizational Change in Chronic Asthma Care : Cost-effectiveness Analysis of the Pediatric Asthma Care Patient Outcomes Research Team II PAC-PORT II. COMMENT. 2 - 5 Compared with the usual-care arm, patients randomized to the PLE arm had an annual increase of 6.5 symptom-free days SFDs , whereas those randomized to the PACI arm had an annual increase of 13.3 SFDs during the study period. View Large | Save Table | Download Slide .ppt | View in Article Context. View Large | Save Table | Download Slide .ppt | View in Article Context. Patients in the usual-care arm of the study had an increase in SFDs of 14.8 per year during the study period. View Large | Save Table | Download Slide .ppt | View in Article Context. The per-pat...
http://archpedi.jamanetwork.com/article.aspx?articleid=486012
*  J Clin Psychiatry/Naturalistic, Retrospective Comparison Between Second-Generation Antipsychot
... ics and Depot Neuroleptics in Patients Affected by Schizophrenia. SITEMAP ——The Journal of Clinical Psychiatry—— Home About JCP Subscribe Archive Information for Authors Information for Reviewers Information for Advertisers Customer Service ——The Primary Care Companion—— Home About PCC Register Archive Information for Authors Information for Reviewers ——Psychiatrist.com—— About Psychiatrist.com Terms of Use Privacy Policy Help ——CME Institute—— All CME Activities MyCME. JCP Full Text. PCC Full Text. JCP and PCC Full Text.   The article you requested is Naturalistic, Retrospective Comparison Between Second-Generation Antipsychotics and Depot Neuroleptics in Patients Affected by Schizophrenia Livio Marchiaro, MD; Paola Rocca, MD; Ferdinando LeNoci, MD; Pierpaolo Longo, MD; Cristiana Montemagni, MD; Cristiana Rigazzi, MD; and Filippo Bogetto, MD J Clin Psychiatry 2005;66 11 :1423-1431. Purchase This PDF for $40.00 If you are not a paid subscriber, you may purchase the PDF. Article Abstract Objective: Dat...
http://psychiatrist.com/JCP/article/Pages/2005/v66n11/v66n1113.aspx
*  Retrospective 40 Blue Slate
... Inventive Camera Bags for All of Your Gear The Choice of Working Professionals. Find Store. Holster Camera Bags. Laptop Bags. Rolling Camera Bags. Shoulder Bags. Share The Moment. Share The Moment. Home > Products > Retrospective > Retrospective® 40 Blue Slate. This bag blends the look and feel of "old-school" camera bags with "new-school" features and technology for the digital imaging age. Key Features Minimalist outer appearance conceals expensive photo equipment Carries a pro DSLR with a 70-200mm f/2.8 zoom lens attached Dedicated slot accommodates most 13" laptops. Gear Profile 1 pro DSLR with standard zoom lens attached and 1 - 3 additional lenses, including a 70-200mm f/2.8 2 pro DSLRs, bodies only in front pockets and 2 - 4 lenses in main compartment, including a 70-200mm f/2.8 1 pro DSLR, stored vertically,with 70-200mm f/2.8 attached. The Retrospective 40 features a dedicated slot for most 13" laptops. All the shoulder bags in the Retrospective series are available in three colors: Blue Slate ...
http://thinktankphoto.com/products/retrospective-40-blue-slate.aspx
*  Alejandro C Arroliga - ResearchGate
... For full functionality of ResearchGate it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser. Alejandro C Arroliga. Scott White, Temple, Texas, United States. Are you Alejandro C Arroliga. Claim your profile. Publications 193 1070.14 Total impact. Article:. Predicting Long-Term Outcomes in Pleural Infections. RAPID Score for Risk Stratification. Heath D White. Christopher Henry. Eileen M Stock Alejandro C Arroliga. Shekhar Ghamande. ABSTRACT: Pleural infections are associated with significant morbidity and mortality. The recently developed RAPID score consists of five clinical factors that can identify patients at risk for increased mortality. The objective of this study is to further validate the RAPID score in a diverse cohort, identify factors associated with mortality, and provide long-term outcomes. We evaluated a single-center retrospective cohort of 187 patients with culture positive pleural infections. Patients were classified by RAPID scores...
http://researchgate.net/researcher/60593980_Alejandro_C_Arroliga
*  Darrell A Russell: person, pictures and information - Fold3.com
... Fold3. Keep me signed in. Set Profile Image Set Background Image Remove Background Image. Darrell Russell. Stories. Allen Davis. Allen Davis Raiders Added by bruceyrock632 28 Sep 2013. Stories. There are no stories about Darrell. Add a story. Pictures Records 1. Add Darrell Russell. Add a photo or record for Darrell A Russell Add. Personal Details Edit Full Name: Darrell A Russell 1. Looking for more information about Darrell A Russell. Find more records. Social Security Death Index. Stories. Former Raiders defensive tackle Darrell Russell, the team's No. Paramedics worked for about 25 minutes using the Jaws of Life to free two men from the wreckage of a 2004 Pontiac Grand Prix. Russell -- whose seven-year, $22 million contract in 1997 was the richest rookie contract ever signed in the NFL -- was pronounced dead at Cedars-Sinai Medical Center. Friends and former teammates of the 6-foot-5, 325-pound Russell -- a Pro Bowl defensive tackle in 1998-99 who missed 1-1/2 years while serving two NFL-mandated sus...
https://fold3.com/page/81097911_darrell_a_russell/
*  Robert Drouin/Marie Duboise
robert drouin marie duboise geneology data and family tree brach husband robert drouin d born abt at mortagne perche orne france married at pin la garenne perche normandy france died wft est at father mother other spouses marie dubois pedigree wife marie duboise d born abt at perche normandy france died unknown at father mother other spouses pedigree sources br derbund family archive vol ed social security death index u s social security death index surnames from a through l date of import nov internal ref family information provided by paulette lachambre home email surnames this page made available by the mayrand family assocation a california non profit corporation we need your help add your family translate a page or two help us correct errors join our very small mailing list mayrand family association sutter street san francisco ca phone contact your cousins this site sponsored and hosted by complete business services page built by gedpage version on september...
http://mayrand.org/HTML/fam/fam04985.html

Temporal analysis of products: Temporal Analysis of Products (TAP), (TAP-2), (TAP-3) is an experimental technique for studyingCognitive behavioral treatment of eating disorders: Cognitive behavioral therapy (CBT) is derived from both the cognitive and behavioral schools of psychology and focuses on the alteration of thoughts and actions with the goal of treating various disorders. The cognitive behavioral treatment of eating disorders emphasizes the minimization of negative thoughts about body image and the act of eating, and attempts to alter negative and harmful behaviors that are involved in and perpetuate eating disorders.QRISK: QRISK2 (the most recent version of QRISK) is a prediction algorithm for cardiovascular disease (CVD) that uses traditional risk factors (age, systolic blood pressure, smoking status and ratio of total serum cholesterol to high-density lipoprotein cholesterol) together with body mass index, ethnicity, measures of deprivation, family history, chronic kidney disease, rheumatoid arthritis, atrial fibrillation, diabetes mellitus, and antihypertensive treatment.Abscopal effect: The abscopal effect is a phenomenon in the treatment of metastatic cancer where localized treatment of a tumor causes not only a shrinking of the treated tumor but also a shrinking of tumors in different compartments from the treated tumor. Initially associated with single-tumor, localized radiation therapy, the term has also come to encompass other types of localized treatments such as electroporation and intra-tumoral injection of therapeutics.Cancer survival rates: Cancer survival rates vary by the type of cancer, stage at diagnosis, treatment given and many other factors, including country. In general survival rates are improving, although more so for some cancers than others.Tuberculosis radiology: Radiology is used in the diagnosis of tuberculosis.Totally drug-resistant tuberculosis: Totally drug-resistant tuberculosis (TDR-TB) is a generic term for tuberculosis strains that are resistant to a wider range of drugs than strains classified as Extensively drug-resistant tuberculosis. TDR-TB has been identified in three countries; India, Iran, and Italy.Multi-drug-resistant tuberculosis: Multi-drug-resistant tuberculosis (MDR-TB) is defined as a form of TB infection caused by bacteria that are resistant] to treatment with at least two of the most powerful [[Therapy#Lines of therapy|first-line anti-TB drugs, isoniazid (INH) and rifampicin (RMP).AIP Conference Proceedings: AIP Conference Proceedings is a serial published by the American Institute of Physics since 1970. It publishes the proceedings from various conferences of physics societies.Prenatal nutrition: Nutrition and weight management before and during :pregnancy has a profound effect on the development of infants. This is a rather critical time for healthy fetal development as infants rely heavily on maternal stores and nutrient for optimal growth and health outcome later in life.Agonist–antagonistSubstance-related disorderMartin Weaver: Martin Weaver is a psychotherapist, author and media writerShanghai Drug Abuse Treatment Centre: The Shanghai Drug Abuse Treatment Centre, or SDATC (), is a governmental organization providing drug abuse treatment and rehabilitation services in Shanghai, China. SDATC is the only government-supported centre in Shanghai and was established in 1997 on the approval of Shanghai Narcotic Control Commission and Shanghai Public Health Bureau.Time-trade-off: Time-Trade-Off (TTO) is a tool used in health economics to help determine the quality of life of a patient or group. The individual will be presented with a set of directions such as:Management of HIV/AIDS: The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs in an attempt to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle.Research Society on Alcoholism: The Research Society on Alcoholism (RSA) is a learned society of over 1600 active members based in Austin, Texas. Its objective is to advance research on alcoholism and the physiological and cognitive effects of alcohol.Combination therapy: Combination therapy or polytherapy is therapy that uses more than one medication or modality (versus monotherapy, which is any therapy taken alone). Typically, these terms refer to using multiple therapies to treat a single disease, and often all the therapies are pharmaceutical (although it can also involve non-medical therapy, such as the combination of medications and talk therapy to treat depression).Age adjustment: In epidemiology and demography, age adjustment, also called age standardization, is a technique used to allow populations to be compared when the age profiles of the populations are quite different.Fort Grey TB HospitalABCD rating: ABCD rating, also called the Jewett staging system or the Whitmore-Jewett staging system, is a staging system for prostate cancer that uses the letters A, B, C, and D.Tuberculosis managementLow-dose chemotherapy: Low-dose chemotherapy is being studied/used in the treatment of cancer to avoid the side effects of conventional chemotherapy. Historically, oncologists have used the highest possible dose that the body can tolerate in order to kill as many cancer cells as possible.Global Risks Report: The Global Risks Report is an annual study published by the World Economic Forum ahead of the Forum’s Annual Meeting in Davos, Switzerland. Based on the work of the Global Risk Network, the report describes changes occurring in the global risks landscape from year to year and identifies the global risks that could play a critical role in the upcoming year.List of Parliamentary constituencies in Kent: The ceremonial county of Kent,Interoceptive exposure: Interoceptive exposure is a cognitive behavioral therapy technique used in the treatment of panic disorder. It refers to carrying out exercises that bring about the physical sensations of a panic attack, such as hyperventilation and high muscle tension, and in the process removing the patient's conditioned response that the physical sensations will cause an attack to happen.Clinical endpoint: In a clinical research trial, a clinical endpoint generally refers to occurrence of a disease, symptom, sign or laboratory abnormality that constitutes one of the target outcomes of the trial, but may also refer to any such disease or sign that strongly motivates the withdrawal of that individual or entity from the trial, then often termed humane (clinical) endpoint.Methadone clinic: A methadone clinic is a clinic which has been established for the dispensing of methadone (Dolophine), a schedule II opioid analgesic, to those who abuse heroin and other opioids. The focus of these clinics is the elimination or reduction of opioid usage by putting the patient on methadone.BrexpiprazoleThe Ted Noffs Foundation Inc: The Ted Noffs Foundation is a nonprofit organization located in Randwick, New South Wales, Australia. Since its foundation in 1992, the foundation has grown from one residential treatment centre for adolescents to a broad range of initiatives, from four residential treatment centres for adolescents with drug and alcohol problems (PALM: Programme for Adolescent Life Management), to adolescent life management aftercare, family and adolescent counselling on an 'outclient' basis, schools counselling, indigenous counselling, an outreach/educational project called 'Street University' and a number of Social Enterprise endeavors such as fashion-oriented op-shops and 'Gideon's Shoes,' dealing in design, manufacture and retailing.Endodontic retreatment: Endodontic retreatment describes a dental root canal procedure that is carried out on a tooth that has previously had root canal treatment. For this reason it is also called "repeat root canal treatment".Community-based clinical trial: Community-based clinical trials are clinical trials conducted directly through doctors and clinics rather than academic research facilities. They are designed to be administered through primary care physicians, community health centers and local outpatient facilities.Regression dilution: Regression dilution, also known as regression attenuation, is the biasing of the regression slope towards zero (or the underestimation of its absolute value), caused by errors in the independent variable.Generalizability theory: Generalizability theory, or G Theory, is a statistical framework for conceptualizing, investigating, and designing reliable observations. It is used to determine the reliability (i.Incidence (epidemiology): Incidence is a measure of the probability of occurrence of a given medical condition in a population within a specified period of time. Although sometimes loosely expressed simply as the number of new cases during some time period, it is better expressed as a proportion or a rate with a denominator.Conference on Retroviruses and Opportunistic Infections: The Conference on Retroviruses and Opportunistic Infections (CROI) is an annual scientific meeting devoted to the understanding, prevention and treatment of HIV/AIDS and the opportunistic infections associated with AIDS. Thousands of leading researchers and clinicians from around the world convene in a different location in North America each year for the Conference.Tumor progression: Tumor progression is the third and last phase in tumor development. This phase is characterised by increased growth speed and invasiveness of the tumor cells.RibavirinS32212: S32212 is a drug which is under preclinical investigation as a potential antidepressant medicine. It behaves as a selective, combined 5-HT2C receptor inverse agonist and α2-adrenergic receptor antagonist (at all three subtypes—α2A, α2B, and α2C) with additional 5-HT2A and, to a lesser extent, 5-HT2B receptor antagonistic properties, and lacks any apparent affinity for the monoamine reuptake transporters or for the α1-adrenergic, H1, or mACh receptors.Sprat: A sprat is the common name applied to a group of forage fish belonging to the genus Sprattus in the family Clupeidae. The term is also applied to a number of other small sprat-like forage fish.Pharmacogenetics: Pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects. The term pharmacogenetics is often used interchangeably with the term pharmacogenomics which also investigates the role of acquired and inherited genetic differences in relation to drug response and drug behavior through a systematic examination of genes, gene products, and inter- and intra-individual variation in gene expression and function.Disease registry: Disease or patient registries are collections of secondary data related to patients with a specific diagnosis, condition, or procedure, and they play an important role in post marketing surveillance of pharmaceuticals. Registries are different from indexes in that they contain more extensive data.Bio Base EuropeNatural cycle in vitro fertilization: Natural Cycle IVF is in vitro fertilisation (IVF) using either of the following procedures:Antileukemic drug: Antileukemic drugs, anticancer drugs that are used to treat one or more types of leukemia, include:Pain scale: A pain scale measures a patient's pain intensity or other features. Pain scales are based on self-report, observational (behavioral), or physiological data.Rating scales for depression: A depression rating scale is a psychiatric measuring instrument having descriptive words and phrases that indicate the severity of depression for a time period. When used, an observer may make judgements and rate a person at a specified scale level with respect to identified characteristics.

(1/106051) Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study.

OBJECTIVE: To evaluate short- and long-term effects of perioperative human growth hormone (hGH) treatment on physical performance and fatigue in younger patients undergoing a major abdominal operation in a normal postoperative regimen with oral nutrition. SUMMARY BACKGROUND DATA: Muscle wasting and functional impairment follow major abdominal surgery. METHODS: Twenty-four patients with ulcerative colitis undergoing ileoanal J-pouch surgery were randomized to hGH (12 IU/day) or placebo treatment from 2 days before to 7 days after surgery. Measurements were performed 2 days before and 10, 30, and 90 days after surgery. RESULTS: The total muscle strength of four limb muscle groups was reduced by 7.6% in the hGH group and by 17.1% in the placebo group at postoperative day 10 compared with baseline values. There was also a significant difference between treatment groups in total muscle strength at day 30, and at the 90-day follow-up total muscle strength was equal to baseline values in the hGH group, but still significantly 5.9% below in the placebo group. The work capacity decreased by approximately 20% at day 10 after surgery, with no significant difference between treatment groups. Both groups were equally fatigued at day 10 after surgery, but at day 30 and 90 the hGH patients were less fatigued than the placebo patients. During the treatment period, patients receiving hGH had reduced loss of limb lean tissue mass, and 3 months after surgery the hGH patients had regained more lean tissue mass than placebo patients. CONCLUSIONS: Perioperative hGH treatment of younger patients undergoing major abdominal surgery preserved limb lean tissue mass, increased postoperative muscular strength, and reduced long-term postoperative fatigue.  (+info)

(2/106051) Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women.

OBJECTIVE: To compare the effect of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment for genuine stress incontinence. DESIGN: Stratified, single blind, randomised controlled trial. SETTING: Multicentre. PARTICIPANTS: 107 women with clinically and urodynamically proved genuine stress incontinence. Mean (range) age was 49.5 (24-70) years, and mean (range) duration of symptoms 10.8 (1-45) years. INTERVENTIONS: Pelvic floor exercise (n=25) comprised 8-12 contractions 3 times a day and exercise in groups with skilled physical therapists once a week. The electrical stimulation group (n=25) used vaginal intermittent stimulation with the MS 106 Twin at 50 Hz 30 minutes a day. The vaginal cones group (n=27) used cones for 20 minutes a day. The untreated control group (n=30) was offered the use of a continence guard. Muscle strength was measured by vaginal squeeze pressure once a month. MAIN OUTCOME MEASURES: Pad test with standardised bladder volume, and self report of severity. RESULTS: Improvement in muscle strength was significantly greater (P=0.03) after pelvic floor exercises (11.0 cm H2O (95% confidence interval 7.7 to 14.3) before v 19.2 cm H2O (15.3 to 23.1) after) than either electrical stimulation (14.8 cm H2O (10. 9 to 18.7) v 18.6 cm H2O (13.3 to 23.9)) or vaginal cones (11.8 cm H2O (8.5 to 15.1) v 15.4 cm H2O (11.1 to 19.7)). Reduction in leakage on pad test was greater in the exercise group (-30.2 g; -43. 3 to 16.9) than in the electrical stimulation group (-7.4 g; -20.9 to 6.1) and the vaginal cones group (-14.7 g; -27.6 to -1.8). On completion of the trial one participant in the control group, 14 in the pelvic floor exercise group, three in the electrical stimulation group, and two in the vaginal cones group no longer considered themselves as having a problem. CONCLUSION: Training of the pelvic floor muscles is superior to electrical stimulation and vaginal cones in the treatment of genuine stress incontinence.  (+info)

(3/106051) Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.

OBJECTIVE: To assess intermittent treatment over 12 months in patients with symptomatic gastro-oesophageal reflux disease. DESIGN: Randomised, multicentre, double blind, controlled study. Patients with heartburn and normal endoscopy results or mild erosive changes received omeprazole 10 mg or 20 mg daily or ranitidine 150 mg twice daily for 2 weeks. Patients remaining symptomatic had omeprazole 10 mg or ranitidine dose doubled for another 2 weeks while omeprazole 20 mg was continued for 2 weeks. Patients who were symptomatic or mildly symptomatic were followed up for 12 months. Recurrences of moderate or severe heartburn during follow up were treated with the dose which was successful for initial symptom control. SETTING: Hospitals and primary care practices between 1994 and 1996. SUBJECTS: 677 patients with gastro-oesophageal reflux disease. MAIN OUTCOME MEASURES: Total time off active treatment, time to failure of intermittent treatment, and outcomes ranked from best to worst. RESULTS: 704 patients were randomised, 677 were eligible for analyses; 318 reached the end of the study with intermittent treatment without recourse to maintenance antisecretory drugs. The median number of days off active treatment during follow up was 142 for the entire study (281 for the 526 patients who reached a treatment related end point). Thus, about half the patients did not require treatment for at least 6 months, and this was similar in all three treatment groups. According to outcome, 378 (72%) patients were in the best outcome ranks (no relapse or one (or more) relapse but in remission until 12 months); 630 (93%) had three or fewer relapses in the intermittent treatment phase. Omeprazole 20 mg provided faster relief of heartburn. The results were similar in patients with erosive and non-erosive disease. CONCLUSIONS: Intermittent treatment is effective in managing symptoms of heartburn in half of patients with uncomplicated gastro-oesophageal reflux disease. It is simple and applicable in general practice, where most patients are seen.  (+info)

(4/106051) Optimal thrombolytic strategies for acute myocardial infarction--bolus administration.

Optimal strategies for thrombolysis in myocardial infarction (TIMI) are still being sought because the TIMI 3 flow rates achievable using standard regimens average approximately 60%. Double bolus administration of recombinant tissue plasminogen activator (tPA) is a novel approach with potential for earlier patency combined with ease of administration. We reviewed total patency rates, TIMI 3 patency rates, mortality, stroke and intracranial haemorrhage rates in the major trials of accelerated infusion tPA/bolus tPA/reteplase in acute myocardial infarction. A direct comparison was performed with results of two recent trials of double bolus (two 50 mg boli, 30 min apart) vs. accelerated infusion tPA: the Double Bolus Lytic Efficacy Trial (DBLE), an angiographic study, and the COBALT Trial, a mortality study. The DBLE trial showed equivalent patency rates for accelerated infusion and double bolus administration of tPA. Reviewing other angiographic trials, total patency and TIMI 3 patency rates achievable with double bolus tPA were comparable to those with accelerated infusion tPA or bolus reteplase administration. The COBALT study demonstrated a 30-day mortality of 7.53% in patients treated with accelerated infusion tPA compared with 7.98% for double bolus tPA treated patients. The small excess in mortality with double bolus treatment was confined to the elderly; in those < or = 75 years, mortality rates were 5.6% and 5.7%, for double bolus and accelerated infusion, respectively, and rates for death or non-fatal stroke were 6.35% and 6.3%, respectively. Comparison with other trials demonstrated mortality, stroke and intracranial haemorrhage rates with double bolus treatment similar to those associated with either accelerated infusion tPA or bolus reteplase treatment. Double bolus administration of tPA to patients with acute myocardial infarction is associated with total patency, TIMI 3 patency, mortality, stroke and intracranial haemorrhage rates similar to those associated with either accelerated infusion of tPA or bolus reteplase.  (+info)

(5/106051) Late referral of end-stage renal failure.

We studied all new patients accepted for renal replacement therapy (RRT) in one unit from 1/1/96 to 31/12/97 (n = 198), to establish time from nephrology referral to RRT, evidence of renal disease prior to referral and the adequacy of renal management prior to referral. Sixty four (32.3%, late referral group) required RRT within 12 weeks of referral. Fifty-nine (29.8%) had recognizable signs of chronic renal failure > 26 weeks prior to referral. Patients starting RRT soon after referral were hospitalized for significantly longer on starting RRT (RRT within 12 weeks of referral, median hospitalization 25.0 days (n = 64); RRT > 12 weeks after referral, median 9.7 days (n = 126), (p < 0.001)). Observed survival at 1 year was 68.3% overall, with 1-year survival of the late referral and early referral groups being 60.5% and 72.5%, respectively (p = NS). Hypertension was found in 159 patients (80.3%): 46 (28.9%) were started on antihypertensive medication following referral, while a further 28 (17.6%) were started on additional antihypertensives. Of the diabetic population (n = 78), only 26 (33.3%) were on an angiotensin-converting-enzyme inhibitor (ACEI) at referral. Many patients are referred late for dialysis despite early signs of renal failure, and the pre-referral management of many of the patients, as evidenced by the treatment of hypertension and use of ACEI in diabetics, is less than optimal.  (+info)

(6/106051) Tumour ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma.

Thirty-seven cirrhotic patients with 62 hepatocellular carcinoma (HCC) foci--most Child-Pugh class B or C and/or with large, inoperable tumours--underwent 148 sessions of transcatheter arterial chemoembolization (TACE) using lipiodol, doxorubicin and cisplatin. Treatment efficacy was assessed by serial hepatic arteriography in 34/37 (91.9%) patients and abdominal CT scanning in 3/37 (8.1%) patients. Child-Pugh status was determined prior to each treatment session. Varying degrees of control of tumour neovascularity occurred for a median 390 days (range 90 to > 1680 days) in 33/34 (97.1%) patients in whom progress hepatic arteriography was performed. Ablation of tumour neovascularity occurred in 6/6 (100%), 4/12 (33.3%) and 6/16 (37.5%) patients with HCC diameters < 4 cm, 4-7 cm and > 8 cm, respectively (p < 0.02). Significantly more sessions were required for ablation of larger tumours (p < 0.05). Recurrent HCC was detected in 50% of patients after a median 240 days (range 60-1120 days). Deterioration in Child-Pugh status followed a session of TACE on 19/148 (12.8%) occasions but resulted in unscheduled hospitalization on only 4/148 (2.7%) occasions, the highest incidence (8.3%) in Child-Pugh C patients. Actuarial survival was 27/36 (75.0%) at 6 months, 17/34 (50.0%) at 12 months, 14/34 (41.2%) at 18 months, 9/31 (29.0%) at 24 months and 4/27 (14.8%) at 36 months. Multi-agent TACE with lipiodol, doxorubicin and cisplatin provides a useful anti-tumour effect, even in cirrhotic patients with large HCCs. The incidence of clinically significant deterioration in hepatic function due to ischaemia of non-tumorous liver is acceptably low, even in Child-Pugh C patients.  (+info)

(7/106051) Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial.

OBJECTIVE: To determine whether interferon-alpha (IFNalpha) reduces the severity of skin involvement in early (<3 years) diffuse scleroderma. METHODS: In a randomized, placebo-controlled, double-blind trial, 35 patients with early scleroderma received subcutaneous injections of either IFNalpha (13.5 x 10(6) units per week in divided doses) or indistinguishable placebo. Outcomes assessed were the modified Rodnan skin score, as determined by a single observer at baseline, 6 months, and 12 months, as well as data on renal, cardiac, and lung function. Pre- and posttreatment skin biopsy samples were analyzed and blood was obtained for assessment of procollagen peptide levels. RESULTS: There were 11 withdrawals from the IFNalpha group and 3 from the placebo group due to either toxicity, lack of efficacy, or death. In the intent-to-treat analysis, there was a greater improvement in the skin score in the placebo group between 0 and 12 months (mean change IFNalpha -4.7 versus placebo -7.5; P = 0.36). There was also a greater deterioration in lung function in patients receiving active therapy, as assessed by either the forced vital capacity (mean change IFNalpha -8.2 versus placebo +1.3; P = 0.01) or the diffusing capacity for carbon monoxide (mean change IFNalpha -9.3 versus placebo +4.7; P = 0.002). Skin biopsy showed no significant decrease in collagen synthesis in the IFNalpha group, and no significant differences in the levels of procollagen peptides were seen between the 2 groups. CONCLUSION: This study suggests that IFNalpha is of no value in the treatment of scleroderma, and that it may in fact be deleterious.  (+info)

(8/106051) Economic consequences of the progression of rheumatoid arthritis in Sweden.

OBJECTIVE: To develop a simulation model for analysis of the cost-effectiveness of treatments that affect the progression of rheumatoid arthritis (RA). METHODS: The Markov model was developed on the basis of a Swedish cohort of 116 patients with early RA who were followed up for 5 years. The majority of patients had American College of Rheumatology (ACR) functional class II disease, and Markov states indicating disease severity were defined based on Health Assessment Questionnaire (HAQ) scores. Costs were calculated from data on resource utilization and patients' work capacity. Utilities (preference weights for health states) were assessed using the EQ-5D (EuroQol) questionnaire. Hypothetical treatment interventions were simulated to illustrate the model. RESULTS: The cohort distribution among the 6 Markov states clearly showed the progression of the disease over 5 years of followup. Costs increased with increasing severity of the Markov states, and total costs over 5 years were higher for patients who were in more severe Markov states at diagnosis. Utilities correlated well with the Markov states, and the EQ-5D was able to discriminate between patients with different HAQ scores within ACR functional class II. CONCLUSION: The Markov model was able to assess disease progression and costs in RA. The model can therefore be a useful tool in calculating the cost-effectiveness of different interventions aimed at changing the progression of the disease.  (+info)


What is the treatment and prognosis of acinetodakter bauminnii?


My mother had a stroke and was in ICU for 3 weeks and then she was moved to a skilled nursing facility. She had pneumonia, surgical and hospital borne. The pneumonia has cleared up, but now the doctors say she has this. What is the treatment and outcome?
----------

Acinetobacter baumannii is a species of pathogenic bacteria called aerobic gram-negative bacillus and is naturally sensitive to relatively few antibiotics.Multidrug-resistant A. baumannii is a common problem in many hospitals in the US and Europe. First line treatment is with a carbapenem antibiotic such as imipenem, but carbapenem resistance is increasingly common. Other treatment options include polymyxins, tigecycline and aminoglycosides.[8]


What is the best treatment for herpes and how effective is it?


What impact does herpes have in a new relationship?  I asked earlier  about timing of telling someone when dating but I need more information such as treatment and outcome.  Can it not be passed on or is this rare?
----------

Valtrate is the medicine that is prescribed this helps if used in small dose daily keep outbreaks at bay.
When outbreak occurs via weeping blisters then Valtrate is doubled  this shortens length and severity of outbreak.
They are after all only small cold sores in clusters, so other than the psychological trauma of knowing that anytime you are rundown  or traumatised in any way outbreaks  do often occur.
You can pass on the virus even when not active by shedding miniscule particles.
Condoms are mandantory to restrict infection during sexual contact  but still not foolproof.
It can't be stressed enough to abstain from sexual contact whilst suffering outbreak as most infectious during this time.
If your partner is fully aware of this and thinks enough of you then it shouldn't be an issue.
Honesty is the only policy as whilst 1 in 5 Americans carry disease some do not even know they carry it.
It might seem a stigma to carry but as said that it can be managed, life is still the same,it's not a death sentence...


how do I apply knowledge of medical terminology to life situation?


I want to write a presentation applying medical terminology to a life situation, including history,symptoms,treatment,outcome using knowledge of medical word part
----------




Can children be hospitalized with diabetes?


if so, what happens? how sick are they? any treatments? outcomes?
----------




Has anyone experienced blood clots in the calf?


What were your symptoms and how long did you wait to get it checked? What was the treatment and outcome? Thanks for your time.
----------




How does the keratin treatment work on african american hair?


Can this treatment be done on relaxed hair.  Should the hair be relaxed and then the keratrin smoothing treatment applied?  Also, on colortreated hair.
----------

Absolutely, Keratin Treatment works on any hair. You apply the treatment in order for your hair to relax, then proceed to brush through it so it becomes more manageable and soft. I have a website for you that explains first-hand experience that I think will come in handy for you. Yes, it works on any hair, including colortreated.


What is the treatment for an abdominal hernia?


What is the treatment for a small abdominal hernia. I have had a small lump in my abdominal wall between the bottom sides of my rib cage for several years. Suddenly it has grown and become painful. Any ideas please?
----------

A hernia that does not cause any problems does not require treatment.

However, since you say that it has grown and is painful, you may need surgery to correct it.  A hernia is caused by a split in the muscle, through which the intestines can protrude.  The biggest problem with a hernia (and the larger, the bigger risk) is that it can become "strangulated", meaning that the intestine becomes pinched enough in that split of the muscle that the tissue can become ischemic (start to die).  This would cause extreme pain, however; you would know if that was the problem!

You didn't mention where exactly the hernia is....I assume by your bellybutton?  Either way, no matter where it is, the surgery to correct it is relatively simple.  They go in and repair the muscle where it is split either by sutures or patch it with a piece of mesh, depending on the size and location of it.  To start, though, see your family doctor and they can point you in the right direction.


Does the keratin hair treatment keep your hair straight even after you wash it?


I am planning on having the treatment done on my hair soon, and I want to know if my hair will revert back after the first wash. Also, do I have to wash my hair right after 72 hours period or can I wash it a little later than that?

 Sorry, I have another question. I play sports all the time. Is there a way to make sure my hair stays straight?
----------

Well..if it is the chemical straightening treatment like the Brazillian Blowout then it will be very smooth and pretty straight but not bone straight. It will be like this for up to 6 months. But ask the stylist to be sure.
You don't have to wash it no.
It will stay smooth with your sports. It may kink a bit if your hair is super curly but it shouldn't.

Have fun! It's awesome if it is like the B.Blow out